1:17-cv-00374 - Bristol Myers Squibb Co et al. v. Hetero Labs Ltd UNITV et al.Report Error
Detail
Case Number
1:17-cv-00374Current Status
closedCause of Action
Infringement
Related Case(s)
1:17-cv-00375
1:17-cv-00376
1:17-cv-00377
1:17-cv-00378
1:17-cv-00379
1:17-cv-00380
1:17-cv-00381
1:17-cv-00382
1:17-cv-00398
1:17-cv-00399
1:17-cv-00400
1:17-cv-00401
1:17-cv-00402
1:17-cv-00403
1:17-cv-00404
1:17-cv-00405
1:17-cv-00406
1:17-cv-00407
1:17-cv-00408
1:17-cv-00409
1:17-cv-00410
1:17-cv-00411
1:17-cv-00412
1:17-cv-00426
1:18-cv-00115
1:19-cv-00055
2020-2229
2020-2252
2020-2258
Court
Delaware District CourtPlaintiff(s)
Bristol Myers Squibb Co
Pfizer Inc
Operating CompanyDefendant(s)
Hetero Labs Ltd UNITV
Zydus Pharmaceuticals USA Inc
Sigmapharm Laboratories LLC
Sunshine Lake LLC
Wockhardt Ltd
Prinston Pharmaceutical Inc
Impax Laboratories LLC
Torrent Pharmaceuticals Ltd
Natco Pharma Ltd
Unichem Laboratories Ltd
Hetero USA Inc
Apotex Inc
Accord Healthcare Inc
Dr Reddys Laboratories Ltd
Hetero Labs Ltd
Sandoz AG
Macleods Pharmaceuticals Ltd
Micro Labs Ltd
Hec Pharm Co Ltd
Sun Pharmaceutical Industries Ltd
Wockhardt Bio AG
Aurobindo Pharma Ltd
Mylan Pharmaceuticals Inc
Bionpharma Inc
Indoco Remedies Ltd
Sunshine Lake Pharma Co Ltd
Emcure Pharmaceuticals Ltd
Invagen Pharmaceuticals Inc
Lupin Ltd
Sun Pharma Global Fze
Judge
Leonard P. StarkFiling Date
2017-04-05Termination Date
2020-08-13Dockets
| Text |
|---|
| CIVIL DOCKET |
| UPDATED CIVIL DOCKET |
| Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA Inc. on 4/6/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) (Entered: 04/06/2017) |
| COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2116712.) - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(nmg) (Entered: 04/06/2017) |
| PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Letter to The Honorable Leonard P. Stark)(Farnan, Michael) (Entered: 09/22/2017) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Protective Order Dispute. (Attachments: # 1 Exhibit 1 - 2)(Phillips, John) (Entered: 12/04/2017) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Defendants December 4, 2017 Letter - re 46 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) (Entered: 12/06/2017) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Mylans December 29, 2017 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Farnan, Michael) (Entered: 01/02/2018) |
| REDACTED VERSION of 84 Letter by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits A-C)(Farnan, Michael) (Entered: 01/09/2018) |
| STIPULATION to Amend the Complaint to Add Natco Pharma Ltd. as a Defendant in the Bionpharma Inc. Matter by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Michael) (Entered: 02/20/2018) |
| [SEALED] Letter to the Honorable Leonard P. Stark from Stamatios Stamoulis regarding Defendants Position on Discovery Dispute - re 110 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Stamoulis, Stamatios) (Entered: 03/06/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Discovery Dispute on Venue. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L)(Farnan, Michael) (Entered: 03/06/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Mylans March 6, 2018 Letter - re 112 Letter,. (Attachments: # 1 Exhibit A)(Farnan, Michael) (Entered: 03/07/2018) |
| [SEALED] Letter to the Honorable Leonard P. Stark from Stamatios Stamoulis regarding Defendants Reply Position on Discovery Dispute - re 110 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Stamoulis, Stamatios) (Entered: 03/07/2018) |
| REDACTED VERSION of 113 Letter, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits A-L)(Farnan, Michael) (Entered: 03/15/2018) |
| REDACTED VERSION of 114 Letter by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A)(Farnan, Michael) (Entered: 03/15/2018) |
| STIPULATION to Amend the Complaint to Add Aurobindo Pharma Ltd. as a Defendant by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Michael) (Entered: 03/15/2018) |
| First AMENDED COMPLAINT against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.- filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Farnan, Michael) (Entered: 03/19/2018) |
| MOTION and Order for Redactions (Unopposed) - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Stamoulis, Stamatios) (Entered: 04/09/2018) |
| Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Discovery Dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Farnan, Michael) (Entered: 05/10/2018) |
| Letter to the Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Limitations on Deposition Discovery. (Attachments: # 1 Exhibit A)(Phillips, John) (Entered: 05/10/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Limitations on Deposition Discovery. (Attachments: # 1 Exhibit B and C)(Phillips, John) (Entered: 05/11/2018) |
| Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Response to Defendants May 10, 2018 Letter - re 155 Order Setting Teleconference,,,,. (Attachments: # 1 Exhibit 5)(Farnan, Brian) (Entered: 05/11/2018) |
| MOTION to Dismiss for Improper Venue - filed by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Text of Proposed Order)(Stamoulis, Stamatios) (Entered: 05/17/2018) |
| [SEALED] DECLARATION re 179 Opening Brief in Support of Brandon M. White by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Stamoulis, Stamatios) (Entered: 05/17/2018) |
| CLAIM Construction Chart by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7 - Part 1 of 2, # 9 Exhibit 7 - Part 2 of 2, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13)(Farnan, Brian) (Entered: 05/18/2018) |
| REDACTED VERSION of 180 Declaration, by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit)(Stamoulis, Stamatios) (Entered: 05/24/2018) |
| [SEALED] DECLARATION re 192 Answering Brief in Opposition of Timothy A. Cook by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24)(Farnan, Michael) (Entered: 06/14/2018) |
| REDACTED VERSION of 193 Declaration,, of Timothy A. Cook by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-24)(Farnan, Michael) (Entered: 06/22/2018) |
| DECLARATION re 204 Claim Construction Opening Brief Declaration of Edmund J. Elder, Jr. in Support of Defendants Opening Claim Construction Brief by Impax Laboratories LLC, Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Attachments 1-2)(Phillips, John) (Entered: 06/22/2018) |
| DECLARATION re 204 Claim Construction Opening Brief Declaration of Wayne J. Genck, Ph.D by Impax Laboratories LLC, Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit A-E)(Phillips, John) (Entered: 06/22/2018) |
| DECLARATION re 204 Claim Construction Opening Brief Declaration of Philip D. Segrest, Jr. in Support of Defendants Consolidated Opening Claim Construction Brief by Impax Laboratories LLC, Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit A-G)(Phillips, John) (Entered: 06/22/2018) |
| DECLARATION re 206 Claim Construction Opening Brief of Timothy A. Cook by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N)(Farnan, Michael) (Entered: 06/22/2018) |
| DECLARATION re 213 Reply Brief of Brandon M. White by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 18, # 2 Exhibit 19, # 3 Exhibit 20)(Stamoulis, Stamatios) (Entered: 07/02/2018) |
| STATEMENT re 202 Letter Plaintiffs Comments on Defendants Technology Tutorial by Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Farnan, Brian) (Entered: 07/27/2018) |
| STATEMENT // Defendants Comments on Plaintiffs Technology Tutorial [DI 203] by Sandoz Inc.. (Attachments: # 1 Exhibit 1 through 11)(Gattuso, Dominick) (Entered: 07/27/2018) |
| DECLARATION re 243 Claim Construction Answering Brief of Timothy A. Cook by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit O, # 2 Exhibit P, # 3 Exhibit Q, # 4 Exhibit R, # 5 Exhibit S, # 6 Exhibit T)(Farnan, Brian) (Entered: 08/03/2018) |
| DECLARATION re 245 Claim Construction Answering Brief Declaration of Dustin L. Taylor in Support of Defendants Consolidated Responsive Claim Construction Brief by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit H-M)(Bilson, David) (Entered: 08/03/2018) |
| DECLARATION re 245 Claim Construction Answering Brief Declaration of P. Branko Pejic in Support of Defendants Consolidated Responsive Claim Construction Brief by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit 1)(Bilson, David) (Entered: 08/03/2018) |
| MOTION to Strike Atwood Artlcle - filed by Unichem Laboratories, Ltd.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 08/17/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding in Support of Motion to Strike Atwood Article - re 258 MOTION to Strike Atwood Artlcle. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Phillips, John) (Entered: 08/17/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Opposition to Defendants Motion to Strike - re 258 MOTION to Strike Atwood Artlcle. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Michael) (Entered: 08/24/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding USL Defendants supplemental slides at Markman hearing. (Attachments: # 1 Attachments 1-4)(Phillips, John) (Entered: 09/07/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Supplemental Claim Construction Information. (Attachments: # 1 Exhibits A-D)(Phillips, John) (Entered: 09/24/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Defendants September 24, 2018 letter - re 315 Letter. (Attachments: # 1 Exhibit A)(Farnan, Michael) (Entered: 09/26/2018) |
| REDACTED VERSION of 315 Letter by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibits A-D)(Phillips, John) (Entered: 10/01/2018) |
| REDACTED VERSION of 324 Letter by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A)(Farnan, Michael) (Entered: 10/03/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney David A. Gerasimow - filed by Sigmapharm Laboratories LLC. (Attachments: # 1 Certification of David A. Gerasimow)(Bilson, David) (Entered: 10/25/2018) |
| Joint STATUS REPORT by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Brian) (Entered: 11/09/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Discovery Dispute between Plaintiffs and Sigmapharm Laboratories, LLC. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Farnan, Michael) (Entered: 11/14/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from David A. Bilson regarding Response to Plaintiffs November 14, 2018 Discovery Dispute Letter - re 416 Letter,. (Attachments: # 1 Exhibit A - H)(Bilson, David) (Entered: 11/20/2018) |
| REDACTED VERSION of 416 Letter, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-7)(Farnan, Michael) (Entered: 11/21/2018) |
| REDACTED VERSION of 427 Letter by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibits A-H)(Bilson, David) (Entered: 11/27/2018) |
| [SEALED] MOTION to Redact Transcript (Unopposed) - filed by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Proposed Order)(Phillips, John) (Entered: 12/11/2018) |
| REDACTED VERSION of 454 MOTION to Redact Transcript (Unopposed) by Sigmapharm Laboratories LLC. (Attachments: # 1 Proposed Order, # 2 Exhibits A-B)(Phillips, John) (Entered: 12/18/2018) |
| MOTION to Strike Paragraph 96 of the Expert Declaration of Dr. MacMillan relating to infringement of U.S. Patent No. 6,967,208, Claim 104 - filed by Sigmapharm Laboratories LLC. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 06/20/2019) |
| [SEALED] Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding in Support of Motion to Strike - re 536 MOTION to Strike Paragraph 96 of the Expert Declaration of Dr. MacMillan relating to infringement of U.S. Patent No. 6,967,208, Claim 104. (Attachments: # 1 Exhibit 1-5)(Phillips, John) (Entered: 06/20/2019) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Answering Letter Brief to Sigmapharms Motion to Strike - re 536 MOTION to Strike Paragraph 96 of the Expert Declaration of Dr. MacMillan relating to infringement of U.S. Patent No. 6,967,208, Claim 104. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Farnan, Michael) (Entered: 07/01/2019) |
| REDACTED VERSION of 545 Letter, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits A-F)(Farnan, Michael) (Entered: 07/11/2019) |
| [SEALED] MOTION to Preclude Portions of the Non-Infringement Testimony of Harry G. Brittain, Ph.D. - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Farnan, Michael) (Entered: 08/07/2019) |
| [SEALED] DECLARATION re 560 MOTION to Preclude a Portion of the Testimony of Wayne J. Genck, Ph.D. of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Michael) (Entered: 08/07/2019) |
| [SEALED] MOTION to Preclude Portions of the Non-Infringement Testimony of Mark Sacchetti, Ph.D. - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) (Entered: 08/07/2019) |
| [SEALED] DECLARATION re 563 MOTION to Preclude Portions of the Non-Infringement Testimony of Robert Schurko and David Apperley of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Farnan, Brian) (Entered: 08/07/2019) |
| [SEALED] DECLARATION re 565 MOTION to Preclude Portions of the Non-Infringement Testimony of Michael Zaworotko, Ph.D. of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Brian) (Entered: 08/07/2019) |
| MOTION to Preclude Motion to Exclude Expert Testimony of Cory J. Berkland, Ph.D. - filed by Unichem Laboratories, Ltd.. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 08/07/2019) |
| [SEALED] MOTION to Preclude Sigmapharms Daubert Motion to Exclude Certain Experts - filed by Sigmapharm Laboratories LLC. (Attachments: # 1 Text of Proposed Order)(Phillips, John) (Entered: 08/07/2019) |
| REDACTED VERSION of 570 MOTION to Preclude Sigmapharms Daubert Motion to Exclude Certain Experts by Sigmapharm Laboratories LLC. (Attachments: # 1 Proposed Order)(Phillips, John) (Entered: 08/14/2019) |
| REDACTED VERSION of 572 Exhibit to a Document by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibits 1-12, # 2 Exhibits 13-20)(Phillips, John) (Entered: 08/14/2019) |
| REDACTED VERSION of 564 Declaration, of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-7)(Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 566 Declaration, of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-5)(Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 559 MOTION to Preclude Portions of the Non-Infringement Testimony of Harry G. Brittain, Ph.D. by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-4)(Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 561 Declaration, of Christa J. Laser by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 562 MOTION to Preclude Portions of the Non-Infringement Testimony of Mark Sacchetti, Ph.D. by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-3)(Farnan, Brian) (Entered: 08/14/2019) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Sigmapharms Request for Leave to File Summary Judgment - re 573 Letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Farnan, Michael) (Entered: 08/14/2019) |
| ANSWERING BRIEF in Opposition re 562 MOTION to Preclude Portions of the Non-Infringement Testimony of Mark Sacchetti, Ph.D. filed by Zydus Pharmaceuticals (USA) Inc..Reply Brief due date per Local Rules is 8/29/2019. (Attachments: # 1 Exhibits 1-4)(Phillips, John) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 594 Response to Motion - Declaration of Karen L. Pascale - by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Attachments: # 1 Exhibit A-G)(Pascale, Karen) (Entered: 08/22/2019) |
| [SEALED] ANSWERING BRIEF in Opposition re 560 MOTION to Preclude a Portion of the Testimony of Wayne J. Genck, Ph.D. filed by Unichem Laboratories, Ltd..Reply Brief due date per Local Rules is 8/29/2019. (Attachments: # 1 Exhibits 1-17)(Phillips, John) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 597 Answering Brief in Opposition, of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22 - Part 1 of 3, # 23 Exhibit 22 - Part 2 of 3, # 24 Exhibit 22 - Part 3 of 3)(Farnan, Brian) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 598 Answering Brief in Opposition, [Declaration of Philip D. Segrest] by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibit A - B)(Phillips, John) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 601 Answering Brief in Opposition, of Charles T. Cox Jr. by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13)(Farnan, Brian) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 603 Answering Brief in Opposition, [Declaration of Philip D. Segrest] by Sigmapharm Laboratories LLC. (Attachments: # 1 Exhibit A - B)(Phillips, John) (Entered: 08/22/2019) |
| [SEALED] DECLARATION re 605 Letter [Declaration of Dustin L. Taylor] by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., HEC Pharm USA Inc., Sigmapharm Laboratories LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Attachments: # 1 Exhibit A - G)(Phillips, John) (Entered: 08/22/2019) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Defendants August 22, 2019 Letter - re 605 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Michael) (Entered: 08/23/2019) |
| [SEALED] DECLARATION re 609 Letter of Melanie Black Dubis by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Stamoulis, Stamatios) (Entered: 08/23/2019) |
| REDACTED VERSION of 595 Declaration by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Attachments: # 1 Exhibit A-G)(Pascale, Karen) (Entered: 08/26/2019) |
| REDACTED VERSION of 596 Answering Brief in Opposition, by Unichem Laboratories, Ltd.. (Attachments: # 1 Exhibit 1 - 17)(Bilson, David) (Entered: 08/29/2019) |
| REDACTED VERSION of 599 Declaration,, of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-22)(Farnan, Brian) (Entered: 08/29/2019) |
| REDACTED VERSION of 602 Declaration, of Charles T. Cox Jr. by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-13)(Farnan, Brian) (Entered: 08/29/2019) |
| [SEALED] DECLARATION re 628 Reply Brief of Charles T. Cox Jr. by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] DECLARATION re 630 Reply Brief of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] DECLARATION re 632 Reply Brief of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] DECLARATION re 635 Reply Brief of Heather M. Petruzzi by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 08/30/2019) |
| REDACTED VERSION of 610 Declaration by Mylan Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Stamoulis, Stamatios) (Entered: 08/30/2019) |
| REDACTED VERSION of 608 Letter, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-5)(Farnan, Michael) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 567 MOTION to Preclude Motion to Exclude Expert Testimony of Cory J. Berkland, Ph.D. Pursuant to Fed. R. Evid. 702 filed by Unichem Laboratories, Ltd.. (Attachments: # 1 Exhibit 23 - 25)(Phillips, John) (Entered: 08/30/2019) |
| REDACTED VERSION of 640 Reply Brief, by Unichem Laboratories, Ltd.. (Attachments: # 1 Exhibit 23-25)(Bilson, David) (Entered: 09/06/2019) |
| REDACTED VERSION of 629 Declaration by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 631 Declaration of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 633 Declaration of Katherine P. Kieckhafer by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 636 Declaration of Heather M. Petruzzi by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-2)(Farnan, Brian) (Entered: 09/06/2019) |
| Letter to The Honorable Jennifer L. Hall from John C. Phillips, Jr. regarding Discovery Dispute (Dr. Munson). (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 09/12/2019) |
| [SEALED] Letter to The Honorable Jennifer L. Hall from Michael J. Farnan regarding Response to Sigmapharms September 12, 2019 Letter - re 662 Letter. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Farnan, Michael) (Entered: 09/16/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Thomas P. Heneghan - filed by Sigmapharm Laboratories LLC. (Attachments: # 1 Certification of Thomas P. Heneghan)(Bilson, David) (Entered: 09/23/2019) |
| REDACTED VERSION of 663 Letter, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-7)(Farnan, Michael) (Entered: 09/23/2019) |
| [SEALED] Proposed Pretrial Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13)(Farnan, Michael) (Attachment 10 replaced on 10/16/2019) (ntl). (Entered: 10/11/2019) |
| REDACTED VERSION of 672 Proposed Pretrial Order, by Bristol-Myers Squibb Company, Pfizer Inc.. (Attachments: # 1 Exhibits 1-13)(Farnan, Michael) (Entered: 10/18/2019) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Thirty Month Stay. (Attachments: # 1 Text of Proposed Order)(Farnan, Michael) (Entered: 06/17/2020) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding response to Plaintiffs June 17, 2020 letter regarding statutory stay - re 725 Letter. (Attachments: # 1 Exhibit 1)(Phillips, John) (Entered: 06/18/2020) |
| Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 04/06/2017) |
| Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/28/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/28/2020. (nmg) (Entered: 04/06/2017) |
| Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,967,208 B2; US 9,326,945 B2. (nmg) (Entered: 04/06/2017) |
| Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bristol-Myers Squibb Company. (nmg) (Entered: 04/06/2017) |
| Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Pfizer Inc. (nmg) (Entered: 04/06/2017) |
| SUMMONS Returned Executed by Bristol-Myers Squibb Company, Pfizer Inc.. Aurobindo Pharma USA Inc. served on 4/7/2017, answer due 4/28/2017. (Farnan, Michael) (Entered: 04/18/2017) |
| STIPULATION TO EXTEND TIME for Defendant to Answer or Otherwise Respond to the Complaint to 6/1/2017 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/03/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Gregory H. Lantier, Tracey C. Allen, Heather M. Petruzzi, Andrew J. Danford, Jeffrey T. Hantson, Timothy A. Cook, and Kevin M. Yurkerwich - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 05/04/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore - filed by Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 05/08/2017) |
| STIPULATION TO EXTEND TIME to Answer or otherwise respond to Complaint to June 15, 2017 - filed by Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 05/25/2017) |
| ANSWER to 1 Complaint, And Affirmative Defenses by Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 06/15/2017) |
| Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 06/21/2017) |
| INITIAL DISCLOSURES pursuant to Rule 26 filed by Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 10/27/2017) |
| NOTICE OF SERVICE of Plaintiffs Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/27/2017) |
| NOTICE OF SERVICE of (i) Plaintiffs First Set of Common Requests for Production of Documents and Things and (ii) Plaintiffs First Set of Common Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/30/2017) |
| SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are CONSOLIDATED for purposes of discovery and all papers shall be filed in Civil Action No. 17-374-LPS. Discovery due by 7/12/2019. Status Report due by 11/30/2018. Claim Construction Opening Brief due by 6/22/2018. Claim Construction Answering Brief due by 7/27/2018. A Markman Hearing is set for 9/4/2018 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 9/20/2019. A Final Pretrial Conference is set for 9/27/2019 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A Bench Trial (at least 5 days) is set for 10/15/2019 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 11/2/17. Associated Cases: 1:17-cv-00374-LPS et al. (ntl) (Entered: 11/02/2017) |
| Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Request for Discovery Teleconference. (Farnan, Brian) (Entered: 11/13/2017) |
| NOTICE OF SERVICE of (1) Apotexs Paragraph 3 Disclosures; (2) Bionpharmas Paragraph 3 Disclosures; and (3) Micro Labs Paragraph 3 Disclosures filed by Apotex Corp., Apotex Inc., Bionpharma Inc., Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USAs Initial Disclosures Pursuant to Section 3 of the Default Standard for Discovery filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendants Hetero USA, Inc., Hetero Labs Ltd., and Hetero Labs Ltd. Unit-Vs Paragraph 3 Disclosures filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc..(Seaman, John) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Indoco Remedies LTD.s ESI Rule 3 Initial Disclosures filed by Indoco Remedies Ltd..(Brennecke, Sean) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendant Sigmapharm Laboratories, LLCs [CONFIDENTIAL] Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendant Impax Laboratories, Inc.s Initial Disclosures under Paragraph 3 of the District of Delawares Default Standard for Discovery filed by Impax Laboratories Inc..(Bilson, David) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendant Unichem Laboratories, Ltd.s Disclosures Pursuant to District Court of Delaware Default Standard for Discovery Paragraph 3 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendants Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendant Emcure Pharmaceuticals Ltd.s Paragraph 3 Disclosures filed by Emcure Pharmaceuticals Ltd..(Stuhlman, Gregory) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Wockhardt Bio AG and Wockhardt USA LLCs Disclosures Pursuant to District of Delaware Default Standard Paragraph 3 filed by Wockhardt Bio AG, Wockhardt USA LLC.(Poff, Adam) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Bristol-Myers Squibb Company and Pfizer Inc.s Disclosure Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Section 3 Initial Disclosures filed by InvaGen Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Defendant Lupin LTD.s Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Lupin Ltd..(Brauerman, Stephen) (Entered: 11/17/2017) |
| NOTICE OF SERVICE of Sandoz Inc.s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery [CONFIDENTIAL Pursuant to D. Del Local Rule 26.2] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 11/17/2017) |
| NOTICE of Appearance by Arun John Mohan on behalf of Lupin Ltd. (Mohan, Arun) (Entered: 11/17/2017) |
| STATUS REPORT regarding Mylan Venue Discovery by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 11/22/2017) |
| Official Transcript of Telephone Conference held on November 15, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/13/2017. Redacted Transcript Deadline set for 12/27/2017. Release of Transcript Restriction set for 2/20/2018.(bpg) (Entered: 11/22/2017) |
| MEMORANDUM ORDER re dispute regarding venue-related discovery. Signed by Judge Leonard P. Stark on 11/28/17. Associated Cases: 1:17-cv-00374-LPS, 1:17-cv-00379-LPS (ntl) (Entered: 11/28/2017) |
| NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL] Initial Disclosures of Sun Pharmaceutical Industries, Inc. and Sun Pharma Global FZE Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Inc..(Bilson, David) (Entered: 11/29/2017) |
| NOTICE OF SERVICE of Defendant Torrent Pharmaceuticals Ltd.s Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Torrent Pharmaceuticals Ltd..(Bilson, David) (Entered: 11/29/2017) |
| STIPULATION of Dismissal Without Prejudice as to Defendant Sunshine Lake LLC and Amending Caption in the Action to Reflect Same by HEC Pharm USA Inc., Sunshine Lake LLC, Sunshine Lake Pharma Co., Ltd.. (Pascale, Karen) (Entered: 11/29/2017) |
| STIPULATION of Dismissal between Plaintiffs and Defendants Hetero USA Inc., Hetero Labs Ltd., and Hetero Labs Ltd. Unit-V by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 12/01/2017) |
| PROPOSED ORDER Proposed Protective Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/13/2017) |
| NOTICE OF SERVICE of Core Technical Documents filed by Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of (1) Apotexs Paragraph 4(b) Disclosures; (2) Bionpharmas Paragraph 4(b) Disclosures; and (3) Micro Labs Paragraph 4(b) Disclosures filed by Apotex Corp., Apotex Inc., Bionpharma Inc., Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 12/15/2017) |
| Official Transcript of Telephone Conference held on December 11, 2017 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/5/2018. Redacted Transcript Deadline set for 1/16/2018. Release of Transcript Restriction set for 3/15/2018. (bpg) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.s Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of ESI Rule 4.b Disclosure of Core Technical Documents filed by Macleods Pharmaceuticals Ltd..(Capuzzi, Kevin) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Defendant Impax Laboratories, Inc.s Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Impax Laboratories Inc..(Phillips, John) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd. and HEC Pharm USAs core technical document production pursuant to the Scheduling Order and Paragraph 4.b. of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Defendant Sigmapharm Laboratories, Inc.s Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Sigmapharm Laboratories LLC.(Phillips, John) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Defendant Lupin LTD.s Production of Core Technical Documents, Bearing Bates Numbers LUPINAPIX0000001-LUPINAPIX0021033 filed by Lupin Ltd..(Brauerman, Stephen) (Entered: 12/15/2017) |
| NOTICE of Notice of Service of Defendant Indoco Remedies LTDs Core Technical Documents Pursuant to Paragraph 4.b. of the Default Standard for Discovery by Indoco Remedies Ltd. (Brennecke, Sean) (Entered: 12/15/2017) |
| NOTICE OF SERVICE of Core Technical Documents filed by Emcure Pharmaceuticals Ltd..(Stuhlman, Gregory) (Entered: 12/15/2017) |
| MOTION for Pro Hac Vice Appearance of Attorney Jamaica P. Szeliga, Dean L. Fanelli and Thomas A. Haag - filed by Indoco Remedies Ltd.. (Brennecke, Sean) (Entered: 12/18/2017) |
| NOTICE OF SERVICE of Wockhardt Bio AGs and Wockhardt USA LLCs Core Technical Documents filed by Wockhardt Bio AG, Wockhardt USA LLC.(Poff, Adam) (Entered: 12/18/2017) |
| STIPULATION of Dismissal between Plaintiffs and Defendant Torrent Pharmaceuticals Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/18/2017) |
| NOTICE OF SERVICE of Defendant InvaGen Pharmaceuticals, Inc.s Core Technical Documents Pursuant to Paragraph 4(b) of the Default Standard of Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by InvaGen Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 12/18/2017) |
| NOTICE OF SERVICE of Dr. Reddys Core Technical Documents filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 12/18/2017) |
| NOTICE OF SERVICE of Prior to 6:00 p.m. on Friday, December 15, 2017--Prinston Pharmaceutical Inc.s Core Technical Documents, Production Bates Range PRIN-APIX_0000001 PRIN-APIX_0013511 filed by Prinston Pharmaceutical Inc..(Renck, Richard) (Entered: 12/18/2017) |
| NOTICE OF SERVICE of Sandoz Inc.s Production of Core Technical Documents bearing Bates numbers SANDOZ-APIX-00000001 through SANDOZ-APIX-00012428 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 12/18/2017) |
| NOTICE to Take Deposition of Keith Meckstroth on 3/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/22/2017) |
| [SEALED] NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. on 3/7/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/22/2017) |
| NOTICE OF SERVICE of (i) Plaintiffs Venue-Related Requests for Production of Documents and Things to Defendant Mylan Pharmaceuticals Inc. and (ii) Plaintiffs Venue-Related Interrogatories to Defendant Mylan Pharmaceuticals Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/22/2017) |
| NOTICE OF SERVICE of DRLs Responses and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24) and DRLs Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 1-10) filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 12/28/2017) |
| NOTICE OF SERVICE of Defendant Indoco Remedies LTD.s Objections and Responses to Plaintiffs Bristol-Myers Squibb Company and Pfizer Inc.s First Set of Common Requests for Production of Documents and Things; and Defendant Indoco Remedies LTD.s Objections and Responses to Plaintiffs Bristol-Myers Squibb Company and Pfizer Inc.s First Set of Common Interrogatories, filed by Indoco Remedies Ltd..(Brennecke, Sean) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of Mylan Pharmaceutical Inc.s Responses to Plaintiffs Written Discovery filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Defendant Impax Laboratories, Inc.s Responses to Plaintiffs First Set of Common Interrogatories; and (2) Defendant Impax Laboratories, Inc.s Responses to Plaintiffs Common Requests for Production of Documents and Things filed by Impax Laboratories Inc..(Phillips, John) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Unichem Laboratories, Ltd.s Response and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-10); and (2) Unichem Laboratories, Ltd.s Responses and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24) filed by Unichem Laboratories, Ltd..(Phillips, John) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Defendant Zydus Pharmaceuticals (USA) Inc.s Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 1-10); and (2) Defendant Zydus Pharmaceuticals (USA) Inc.s Responses and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24) filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Apotexs Response to Plaintiffs First Set of Common Interrogatories; (2) Apotexs Response and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things; (3) Bionpharmas Response to Plaintiffs First Set of Common Interrogatories; (4) Bionpharmas Response and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things; (5) Micro Labs Response to Plaintiffs First Set of Common Interrogatories and (6) Micro Labs Response and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things filed by Apotex Corp., Apotex Inc., Bionpharma Inc., Micro Labs Ltd., Micro Labs USA Inc..(Dorsney, Kenneth) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of Notice of Service filed by Prinston Pharmaceutical Inc..(Renck, Richard) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of 1) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24); and 2) Defendant Sandoz Inc.s Objections and Answers to Plaintiffs First Set of Common Interrogatories (Nos. 1-10) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Defendant Sigmapharm Laboratories, LLCs Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-10); and (2) Defendant Sigmapharm Laboratories, LLCs Responses to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24) filed by Sigmapharm Laboratories LLC.(Phillips, John) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) Defendant InvaGen Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs First Set of Common Interrogatories and (2) Defendant InvaGen Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs First Set of Common Requests for Production of Documents and Things filed by InvaGen Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of (1) DEFENDANT LUPIN LTD.S OBJECTIONS AND RESPONSES TO PLAINTIFFS FIRST SET OF COMMON INTERROGATORIES (NOS. 1-10) and (2) DEFENDANT LUPIN LTD.S RESPONSES AND OBJECTIONS TO PLAINTIFFS FIRST SET OF COMMON REQUESTS FOR PRODUCTION OF DOCUMENTS AND THINGS filed by Lupin Ltd..(Brauerman, Stephen) (Entered: 12/29/2017) |
| NOTICE OF SERVICE of Aurobindo Pharma USA Inc.s Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-10) and Responses to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24) filed by Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 12/29/2017) |
| REDACTED VERSION of 68 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 01/02/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth - filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 01/03/2018) |
| REDACTED VERSION Letter Regarding Discovery Dispute by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 01/05/2018) |
| NOTICE OF SERVICE of 1) Wockhardt Bio AG and Wockhardt USA LLCs Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1 10); and 2) Wockhardt Bio AG and Wockhardt USA LLCs Objections and Responses to Plaintiffs First Set of Requests for Production of Document and Things filed by Wockhardt Bio AG, Wockhardt USA LLC.(Poff, Adam) (Entered: 01/05/2018) |
| NOTICE OF SERVICE of 1) Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 1-24), and 2) Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 1-10) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 01/05/2018) |
| STIPULATION of Dismissal of Defendant Macleods Pharmaceuticals Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 01/08/2018) |
| PROPOSED ORDER Protective Order for Mylan Venue Discovery by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 01/12/2018) |
| STIPULATION of Dismissal of Defendant Emcure Pharmaceuticals Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 01/15/2018) |
| STIPULATION of Dismissal of Defendants Sun Pharmaceutical Industries Inc. and Sun Pharma Global FZE by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 01/15/2018) |
| STIPULATION of Dismissal of Defendants Apotex Inc. and Apotex Corp. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 01/16/2018) |
| NOTICE OF SERVICE of Plaintiffs Objections & Responses to Mylan Pharmaceuticals Inc.s First Set of Individual Requests for Documents and Things filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 01/16/2018) |
| NOTICE requesting Clerk to remove Sri K. Sankaran and Devan V. Padmanabhan as co-counsel.. (Brennecke, Sean) (Entered: 01/17/2018) |
| [SEALED] Official Transcript of Telephone Conference held on January 5, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/9/2018. Redacted Transcript Deadline set for 2/20/2018. Release of Transcript Restriction set for 4/19/2018. (bpg) (Entered: 01/19/2018) |
| STIPULATION of Dismissal of Micro Labs USA Inc. and Micro Labs, Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 01/24/2018) |
| NOTICE OF SERVICE of Discovery Requests filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 01/25/2018) |
| STIPULATION TO EXTEND TIME to Submit Discovery Dispute to January 30, 2018 - filed by Bristol-Myers Squibb Company. (Farnan, Brian) (Entered: 01/26/2018) |
| STIPULATION TO EXTEND TIME to Submit Discovery Dispute to 2/19/2018 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 01/30/2018) |
| STIPULATION TO EXTEND TIME to Serve Initial Infringement Contentions in Bionpharma Case to March 2, 2018 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 02/14/2018) |
| ANSWER to 1 Complaint, Defenses, COUNTERCLAIM against Bristol-Myers Squibb Company by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 02/14/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Mylan Discovery Dispute. (Farnan, Michael) (Entered: 02/16/2018) |
| NOTICE OF SERVICE of Bristol-Myers Squibb Company and Pfizer Inc.s Preliminary Infringement Contentions filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 02/16/2018) |
| NOTICE of of Change of Address by Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) (Entered: 02/22/2018) |
| ANSWER to 103 Answer to Complaint, Counterclaim by Bristol-Myers Squibb Company.(Farnan, Michael) (Entered: 02/23/2018) |
| STIPULATION TO EXTEND TIME to Serve Infringement Contentions to March 16, 2018 - filed by Bristol-Myers Squibb Company. (Farnan, Michael) (Entered: 03/01/2018) |
| STIPULATION of Dismissal of Defendants Bionpharma Inc. and Natco Pharma Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 03/06/2018) |
| STIPULATION concerning Venue-Related Discovery Protective Order re 91 Proposed Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 03/08/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney James E. Nealon of Withers Bergman LLP - filed by Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 03/09/2018) |
| REDACTED VERSION of 112 Letter, by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 03/14/2018) |
| [SEALED] Official Transcript of Telephone Conference held on March 9, 2018 before Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. (bpg) Modified on 4/13/2018 (ntl). (Entered: 03/15/2018) |
| REDACTED VERSION of 115 Letter, by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 03/15/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s First Supplemental Responses and Objections to Plaintiffs First Set of Common Requests for Production of Documents and Things (Nos. 3, 4, and 5); and Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Supplemental Responses and Objections to Plaintiffs First Set of Common Interrogatories (Nos. 2, 4, 5, and 10) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 03/27/2018) |
| STIPULATION TO EXTEND TIME to Respond to the First Amended Complaint to April 9, 2018 - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 03/28/2018) |
| NOTICE OF SERVICE of (i) Plaintiffs Objections & Responses to Defendants First Set of Joint Interrogatories and (ii) Plaintiffs Objections & Responses to Defendants First Set of Joint Requests for Documents and Things filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 03/28/2018) |
| STIPULATION and Order of Dismissal as to Prinston Pharmaceutical Inc. (ntl) (Entered: 04/05/2018) |
| NOTICE OF SERVICE of Defendants First Amended Initial Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and Defendants Amended Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 04/06/2018) |
| ANSWER to Amended Complaint, re: 124 Amended Complaint and Affirmative Defenses by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 04/09/2018) |
| Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aurobindo Pharma Ltd.. (Connolly, Arthur) (Entered: 04/09/2018) |
| [SEALED] STIPULATION of Partial Dismissal by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 04/12/2018) |
| NOTICE OF SERVICE of Indoco Remedies LTD.s First Set of Individual Requests for Documents and Things to Plaintiffs filed by Indoco Remedies Ltd..(Brennecke, Sean) (Entered: 04/16/2018) |
| NOTICE OF SERVICE of Sigmapharms First Set of Individual Requests for Documents and Things to Plaintiffs (Nos. 1-8) filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 04/16/2018) |
| NOTICE OF SERVICE of Plaintiffs Second Set of Common Requests for Production of Documents and Things filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 04/16/2018) |
| NOTICE OF SERVICE of Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 04/16/2018) |
| NOTICE OF SERVICE of Defendants Second Set of Joint Requests for Documents and Things to Plaintiffs filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/16/2018) |
| NOTICE OF SERVICE of (a) Aurobindos First Set of Requests for Documents and Things (Nos. 1-35), and, (b) Notice of Joinder to Defendants Second Set of Joint Requests for Documents and Things to Plaintiffs, dated April 16, 2018 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 04/17/2018) |
| Redaction of 119 Transcript. Telephone conference before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan (302) 573-6360. (bpg) (Entered: 04/17/2018) |
| REDACTED VERSION of 133 Stipulation by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 04/18/2018) |
| STIPULATION TO EXTEND TIME by which Defendants shall produce to the Plaintiffs its initial invalidity contentions to April 30, 2018 - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Poff, Adam) (Entered: 04/19/2018) |
| NOTICE of Indoco Remedies Ltd.s Invalidity Contentions by Indoco Remedies Ltd. (Brennecke, Sean) (Entered: 04/20/2018) |
| NOTICE OF SERVICE of Defendants Preliminary Invalidity Contentions Relating to U.S. Patent No. 6,967,208 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/21/2018) |
| NOTICE OF SERVICE of Defendants Preliminary Invalidity Contentions Relating to U.S. Patent No. 9,326,945 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 04/21/2018) |
| STIPULATION TO EXTEND TIME for Defendants to produce to the Plaintiffs initial invalidity contentions, as well as the related invalidating references to May 10, 2018 - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Poff, Adam) (Entered: 05/01/2018) |
| NOTICE of Change of Firm by Mylan Pharmaceuticals Inc. (Stamoulis, Stamatios) (Entered: 05/01/2018) |
| NOTICE of Withdrawal (Thomas R. Burns) by Sandoz Inc. (Gattuso, Dominick) (Entered: 05/02/2018) |
| STIPULATION of Dismissal of Defendant Lupin Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/04/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s First Set of Interrogatories (No. 1) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 05/04/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Request for Discovery Teleconference. (Farnan, Michael) (Entered: 05/04/2018) |
| NOTICE OF SERVICE of Plaintiffs Claim Construction Disclosure filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/04/2018) |
| NOTICE OF SERVICE of Defendants Preliminary Proposed Claim Terms for Construction filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/04/2018) |
| NOTICE OF SERVICE of Unichems Preliminary Proposed Claim Terms and Constructions filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 05/07/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Kevin S. Prussia - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 05/09/2018) |
| STIPULATION of Dismissal of Defendants Wockhardt Bio AG and Wockhardt USA LLC by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/10/2018) |
| NOTICE OF SERVICE of Sandoz Inc.s Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery [CONFIDENTIAL - SUBJECT TO PROTECTIVE ORDER] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/11/2018) |
| DISCOVERY DEPOSITION ORDER re Addendum to 19 Scheduling Order. Signed by Judge Leonard P. Stark on 5/14/18. (ntl) (Entered: 05/14/2018) |
| Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc. for Impax Laboratories Inc. filed by Impax Laboratories Inc.. (Bilson, David) (Entered: 05/15/2018) |
| NOTICE OF SERVICE of (1) Defendant InvaGen Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things and (2) Defendant InvaGen Pharmaceuticals, Inc.s Objections and Responses to Plaintiffs Second Set of Common Requests for Production of Documents and Things filed by InvaGen Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of Indoco Remedies LTD.s Objections and Responses to Plaintiffs Bristol-Myers Squibb Company and Pfizer Inc.s Second Set of Common Requests for Production of Documents and Things filed by Indoco Remedies Ltd..(Brennecke, Sean) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of 1) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things (No. 1), and 2) Defendant Sandoz Inc.s Objections and Responses to Plaintiffs Second Set of Common Requests for the Production of Documents and Things (No. 25) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (i) Plaintiffs Objections and Responses to Defendants Second Set of Joint Requests for Documents and Things; (ii) Plaintiffs Objections and Responses to Defendant Indoco Remedies Ltd.s First Set of Requests for Documents and Things; and (iii) Plaintiffs Objections and Responses to Sigmapharm Laboratories LLCs First Set of Individual Requests for Documents and Things filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of Aurobindos Responses to 1st Defendant-Specific Requests for Production and Aurobindos Responses to 2nd Common Requests for Production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs Second Set of Common Requests for the Production of Documents (No. 25) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Responses and Objections to Plaintiffs Second Set of Common Requests for Production of Documents and Things (No. 25) filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (1) Defendant Impax Laboratories, Inc.s [CONFIDENTIAL] Responses to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Impax Laboratories, Inc.; and (2) Defendant Impax Laboratories, Inc.s Responses to Plaintiffs Second Set of Common Requests for Production of Documents and Things filed by Impax Laboratories Inc..(Bilson, David) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (1) Sigmapharms Answer to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Sigmapharm Laboratories, LLC; and (2) Sigmapharms Answer to Plaintiffs Second Set of Common Requests for Production of Documents and Things filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (1) Unichem Laboratories, Ltd.s [CONFIDENTIAL] Responses and Objections to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things; and (2) Unichem Laboratories, Ltd.s [CONFIDENTIAL] Responses and Objections to Plaintiffs Second Set of Common Requests for Production of Documents and Things (No. 25) filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (1) Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Objections and Responses to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things (Nos. 1); and (2) Defendant Zydus Pharmaceuticals (USA) Inc.s Objections and Responses to Plaintiffs Second Set of Common Requests for Production of Documents and Things (No. 25) filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 05/16/2018) |
| NOTICE OF SERVICE of (1) Mylan Pharmaceutical Inc.s Responses and Objections to Plaintiffs Second Set of Common Requests for Production of Documents and Things and (2) Mylan Pharmaceutical Inc.s Responses and Objections to Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 05/17/2018) |
| [SEALED] OPENING BRIEF in Support re 178 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 5/31/2018. (Stamoulis, Stamatios) (Entered: 05/17/2018) |
| STIPULATION TO EXTEND TIME for Plaintiffs to file their Opposition to Defendant Mylan Pharmaceuticals Inc.s Renewed Motion to Dismiss or Transfer to 6/14/2018 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/18/2018) |
| REDACTED VERSION of 179 Opening Brief in Support by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 05/24/2018) |
| NOTICE OF SERVICE of (i) Plaintiffs Second Set of Common Interrogatories; (ii) Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things to Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.; (iii) Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Sigmapharm Laboratories, LLC; (iv) Plaintiffs First Set of Defendant-Specific Requests for Production of Documents and Things to Defendants Sunshine Lake Pharma Co., Ltd., Sunshine Lake LLC, and HEC Pharm USA Inc.; (v) Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Unichem Laboratories Ltd.; and (vi) Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Zydus Pharmaceuticals (USA) Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/31/2018) |
| NOTICE OF SERVICE of Plaintiffs Objections and Responses to Sunshine Lake Pharma Co. Ltd.s and HEC Pharm USA Inc.s First Set of Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 06/04/2018) |
| NOTICE of Withdrawal by Sandoz Inc. (Gattuso, Dominick) (Entered: 06/06/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Erin M. Forbes - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 06/06/2018) |
| STIPULATION and [Proposed] Order to Reflect Name Change by Impax Laboratories Inc.. (Bilson, David) (Entered: 06/07/2018) |
| Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals LLC for Impax Laboratories LLC filed by Impax Laboratories LLC. (Bilson, David) (Entered: 06/12/2018) |
| Joint STIPULATION Seeking Modification of Certain Dates re 19 Scheduling Order,,, by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 06/12/2018) |
| [SEALED] ANSWERING BRIEF in Opposition re 178 MOTION to Dismiss for Improper Venue filed by Bristol-Myers Squibb Company, Pfizer Inc..Reply Brief due date per Local Rules is 6/21/2018. (Farnan, Michael) (Entered: 06/14/2018) |
| STIPULATION to Extend Page Limits for Claim Construction Briefs by Bristol-Myers Squibb Company. (Farnan, Brian) (Entered: 06/15/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding July 12, 2018 Hearing. (Farnan, Michael) (Entered: 06/19/2018) |
| NOTICE requesting Clerk to remove Maegan A. Fuller as co-counsel. Reason for request: no longer associated with the Lerner David Firm. (Pascale, Karen) (Entered: 06/20/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs First Set of Defendant-Specific Requests for the Production of Documents and Things to Defendants Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA Inc. filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 06/20/2018) |
| REDACTED VERSION of 192 Answering Brief in Opposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/22/2018) |
| Letter to The Honorable Leonard P. Stark from Dominick T. Gattuso regarding // Enclosing USB drive containing defendants tutorial on the technology at issue. (Gattuso, Dominick) (Entered: 06/22/2018) |
| NOTICE of filing the following Non-Paper material(s) in multi media format: two discs containing Plaintiffs Technology Tutorial. Original Non-paper material(s) to be filed with the Clerk`s Office. Notice filed by Michael J. Farnan on behalf of Bristol-Myers Squibb Company, Pfizer Inc. (Farnan, Michael) (Entered: 06/22/2018) |
| CLAIM CONSTRUCTION OPENING BRIEF Defendants Consolidated Opening Claim Construction Brief filed by Impax Laboratories LLC, Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) (Entered: 06/22/2018) |
| CLAIM CONSTRUCTION OPENING BRIEF filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/22/2018) |
| STIPULATION of Dismissal of Impax Laboratories, LLC by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/28/2018) |
| NOTICE OF SERVICE of Defendant Sigmapharm Laboratories, LLCs [COMPETITIVELY SENSITIVE CONFIDENTIAL INFORMATION OF SIGMAPHARM LABORATORIES, LLC - SUBJECT TO PROTECTIVE ORDER](1) Responses to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17); and (2) Responses to Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things to Defendant Sigmapharm Laboratories, LLC filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 07/02/2018) |
| [SEALED] REPLY BRIEF re 178 MOTION to Dismiss for Improper Venue filed by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of Defendant InvaGen Pharmaceuticals, Inc.s Objections And Responses To Plaintiffs Second Set Of Common Interrogatories filed by InvaGen Pharmaceuticals Inc..(Ormerod, Eve) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of Aurobindos Responses to 2nd Common Interrogatories (11-17) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of (1) Unichem Laboratories, Ltd.s [CONFIDENTIAL] Responses and Objections to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17); and (2) Unichem Laboratories, Ltd.s [CONFIDENTIAL] Responses and Objections to Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of Defendant Sandoz Inc.s Objections and Answers to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17) [Confidential - Subject to Protective Order] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of (1) Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Objections and Responses to Plaintiffs Second Set of Defendant-Specific Requests for Production of Documents and Things (No. 2); and (2) Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Responses and Objections to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17) filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Amended Initial Disclosures Pursuant to Paragraph 3 of Delawares Default Standard for Discovery and Mylan Pharmaceutical Inc.s Responses and Objections to Plaintiffs Second Set of Common Interrogatories filed by Mylan Pharmaceuticals Inc..(Weinblatt, Richard) (Entered: 07/02/2018) |
| NOTICE OF SERVICE of Defendant Indoco Remedies LTD.s Objections and Responses to Plaintiffs Bristol-Myers Squibb Company and Pfizer Inc.s Second Set of Common Interrogatories filed by Indoco Remedies Ltd..(Brennecke, Sean) (Entered: 07/03/2018) |
| NOTICE requesting Clerk to remove C. Kyle Musgrove, Elizabeth Crompton and Scott Cunning as co-counsel. Reason for request: Impax has been dismissed from case. (Bilson, David) (Entered: 07/03/2018) |
| NOTICE OF SERVICE of Dr. Reddys Responses and Objections to Plaintiffs First Set of Defendant Specific Requests for Production of Documents and Things (No. 1) (Competitively Sensitive Confidential Information of Dr. Reddys - Subject to Protective Order) and Dr. Reddys Responses and Objections to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17) filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 07/03/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs Second Set of Common Interrogatories (Nos. 11-17) filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 07/06/2018) |
| REDACTED VERSION of 213 Reply Brief by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 07/10/2018) |
| NOTICE to Take Deposition of Dr. Edmund J. Elder, Jr. on July 20, 2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 07/10/2018) |
| NOTICE to Take Deposition of Dr. Wayne J. Genck on July 19, 2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 07/10/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding the Markman hearing. (Phillips, John) (Entered: 07/13/2018) |
| NOTICE OF SERVICE of Sandoz Inc.s Second Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery [Confidential - Subject to Protective Order] filed by Sandoz Inc..(Nelson, Aaron) (Entered: 07/13/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Katherine P. Kieckhafer - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 07/16/2018) |
| STIPULATION TO EXTEND TIME for the substantial completion of document production and to file a motion to join other parties to July 30, 2018 and August 10, 2018 - filed by Indoco Remedies Ltd.. (Brennecke, Sean) (Entered: 07/16/2018) |
| Official Transcript of Oral Argument Hearing before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/15/2018. Redacted Transcript Deadline set for 8/27/2018. Release of Transcript Restriction set for 10/23/2018. (bpg) (Entered: 07/25/2018) |
| STIPULATION TO EXTEND TIME to EXTEND the deadline for the parties to file Answering Claim Construction Briefs to 8/3/2018 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 07/26/2018) |
| NOTICE requesting Clerk to remove Michael Choi as co-counsel. Reason for request: No longer associated with Budd Larner, P.C.. (Ormerod, Eve) (Entered: 07/31/2018) |
| NOTICE OF SERVICE of Bristol-Myers Squibb Company and Pfizer Inc.s Amended Preliminary Infringement Contentions to Certain Defendants filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/01/2018) |
| [SEALED] STIPULATION of Dismissal by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/01/2018) |
| NOTICE requesting Clerk to remove Jeffrey Hantson as co-counsel.. (Farnan, Michael) (Entered: 08/02/2018) |
| REDACTED VERSION of (239 in 1:17-cv-00374-LPS) Stipulation of Dismissal by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/03/2018) |
| Joint Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Claim Construction Hearing. (Farnan, Brian) (Entered: 08/03/2018) |
| CLAIM CONSTRUCTION ANSWERING BRIEF filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/03/2018) |
| CLAIM CONSTRUCTION ANSWERING BRIEF Defendants Consolidated Responsive Claim Construction Brief filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 08/03/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Christa J. Laser - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/10/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Annaleigh E. Curtis - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/10/2018) |
| NOTICE to Take Deposition of Charles Frost on October 1, 2018 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Chandra Vemavarapu on September 28, 2018 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Jingpin Jia on September 27, 2018 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Donald J. Pinto on September 17, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Jennifer Qiao on September 24, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Michael Orwat on September 19, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2018) |
| NOTICE to Take Deposition of Mimi Quan on September 18, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/16/2018) |
| [SEALED] NOTICE to Take Deposition of Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Indoco Remedies Ltd. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of InvaGen Pharmaceuticals, Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Sandoz Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Sigmapharm Laboratories, LLC filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Sunshine Lake Pharma Co., Ltd., Sunshine Lake LLC, and HEC Pharm USA Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Unichem Laboratories, Ltd. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| [SEALED] NOTICE to Take Deposition of Zydus Pharmaceuticals (USA) Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 08/23/2018) |
| NOTICE OF SERVICE of Dr. Reddys First Set of Individual Requests for Admission (Nos. 1-5) (Contains Competitively Sensitive Confidential Information of Dr. Reddys - Subject to Protective Order) filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 08/24/2018) |
| NOTICE OF SERVICE of Mylan Pharmaceutical Inc.s Supplemental Responses and Objections to Plaintiffs First Set of Common Interrogatories filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/24/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s Supplemental Responses and Objections to Plaintiffs Interrogatory Nos. 5 and 6 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 08/28/2018) |
| REDACTED VERSION of 268 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| REDACTED VERSION of 261 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| REDACTED VERSION of 267 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| REDACTED VERSION of 269 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding reply in support of USL Defendants Motion to Strike - re 258 MOTION to Strike Atwood Artlcle. (Phillips, John) (Entered: 08/28/2018) |
| REDACTED VERSION of 263 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| REDACTED VERSION of 265 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| REDACTED VERSION of 266 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/28/2018) |
| Letter to The Hon. Leonard P. Stark from John C. Phillips, Jr. regarding Motion to Strike - re 258 MOTION to Strike Atwood Artlcle. (Phillips, John) (Entered: 08/28/2018) |
| REDACTED VERSION of 264 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/29/2018) |
| REDACTED VERSION of 262 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/29/2018) |
| NOTICE to Take Deposition of Jatin Patel (Pursuant to Rule 30(b)(1)) on October 24, 2018 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 08/30/2018) |
| REDACTED VERSION of 260 Notice to Take Deposition by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2018) |
| NOTICE to Take Deposition of Patrick Y. S. Lam on October 25, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/30/2018) |
| NOTICE to Take Deposition of Stephanie L. Koch on October 16, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/30/2018) |
| NOTICE to Take Deposition of Wei Han on October 17, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/30/2018) |
| NOTICE OF SERVICE of Defendants Second Set of Joint Interrogatories to Plaitniss (18-21) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 08/30/2018) |
| NOTICE to Take Deposition of Bristol-Myers Squibb Company Pursuant to 30(b)(6) filed on behalf of Defendants filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 09/04/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney James Nealon - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Connolly, Arthur) (Entered: 09/05/2018) |
| NOTICE of Appearance by Jennifer M. Rutter on behalf of InvaGen Pharmaceuticals Inc. (Rutter, Jennifer) (Entered: 09/05/2018) |
| Official Transcript of Claim Construction Hearing held on September 6, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/2/2018. Redacted Transcript Deadline set for 10/12/2018. Release of Transcript Restriction set for 12/10/2018. (bpg) (Entered: 09/11/2018) |
| NOTICE OF SERVICE of Sigmapharm Laboratories, LLCs [CONFIDENTIAL] First Set of Defendant Interrogatories to Plaintiffs (Nos. 1-4) filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 09/14/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Kevin P. Burke and Katie A. Boda - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 09/18/2018) |
| STIPULATION of Dismissal by Bristol-Myers Squibb Company. (Farnan, Michael) (Entered: 09/18/2018) |
| NOTICE OF SERVICE of Plaintiff Bristol-Myers Squibb Co.s Responses and Objections to Defendants Rule 30(b)(6) Notice and Plaintiff Bristol-Myers Squibb Co.s Designated Witnesses in Response to Defendants Rule 30(b)(6) Notice filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 09/18/2018) |
| NOTICE OF SERVICE of Defendant Sandoz Inc.s Supplemental Objections and Answers to Plaintiffs First Set of Common Interrogatories (Nos. 3-5, 7, 9-10) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/19/2018) |
| NOTICE to Take Deposition of Charles Frost on September 27, 2018//Amended Notice filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Jingpin Jia on October 18, 2018 / Amended Notice filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Jatin Patel on October 10, 2018 / Amended Notice filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Chandra Vemavarapu on October 24, 2018 / Amended Notice filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/21/2018) |
| NOTICE OF SERVICE of Plaintiff Bristol-Myers Squibb Company and Pfizer Inc.s Response to Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Frist Set of Individual Requests for Admission (Nos. 1-5) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 09/21/2018) |
| NOTICE OF SERVICE of Plaintiffs First Amended Supplemental Objections & Responses to Defendants First Set of Joint Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Donald J. Pinto on October 9, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Jennifer X. Qiao on October 23, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Michael J. Orwat on October 17, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Mimi L. Quan on November 15, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Patrick Y. S. Lam on November 1, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Stephanie L. Koch on October 16, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE to Take Deposition of Wei Han on October 26, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/21/2018) |
| NOTICE OF SERVICE of (1) Defendant Unichem Laboratories Ltd.s [CONFIDENTIAL] Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6); and (2) Defendant Unichem Laboratories Ltd.s [CONFIDENTIAL] Designated Witness in Response to Plaintiffs Rule 30(b)(6) Notice filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of Sigmapharm Laboratories, LLCs [CONFIDENTIAL] Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of (1) Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6); and (2) Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Designated Witnesses in Response to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of 1) Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Responses and Objections to Plaintiffs Rule 30(b)(6) Notice, and 2) Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Designation of Witness in Response to Plaintiffs Rule 30(b)(6) Notice filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of Sandoz Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) [Competitively Sensitive Confidential Information of Sandoz Inc. - Subject to Protective Order] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of DR. REDDYS LABORATORIES, LTD. AND DR. REDDYS LABORATORIES, INC.S OBJECTIONS AND RESPONSES TO PLAINTIFFS NOTICE OF DEPOSITION PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 30(b)(6) [COMPETITIVELY SENSITIVE CONFIDENTIAL INFORMATION OF DR. REDDYS-SUBJECT TO PROTECTIVE ORDER]; and DR. REDDYS LABORATORIES, LTD. AND DR. REDDYS LABORATORIES, INC.S DESIGNATED WITNESSES IN RESPONSE TO PLAINTIFFS NOTICE OF DEPOSITION PURSUANT TO FEDERAL RULE OF CIVIL PROCEDURE 30(b)(6) [COMPETITIVELY SENSITIVE CONFIDENTIAL INFORMATION OF DR. REDDYS-SUBJECT TO PROTECTIVE ORDER] filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 09/24/2018) |
| NOTICE of Service of Defendant Indoco Remedies Ltd.s Objections and Responses to Plaintiffs Bristol-Myers Squibb Company and Pfizer Inc.s Rule 30(b)(6) Notice and Defendant Indoco Remedies Ltd.s Designated Witnesses in Response to Plaintiffs Rule 30(b)(6) Notice by Indoco Remedies Ltd. (Brennecke, Sean) (Entered: 09/24/2018) |
| NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.s Designated Witnesses in Response to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) and Mylan Pharmaceutical Inc.s Responses and Objections to Plaintiffs Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/24/2018) |
| NOTICE to Take Deposition of Anthony Mancini on November 1, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/26/2018) |
| NOTICE to Take Deposition of Robert Knabb on November 9, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/26/2018) |
| NOTICE to Take Deposition of Ruth Wexler on November 16, 2018 filed by Mylan Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 09/26/2018) |
| NOTICE to Take Deposition of Disha Patel on 11/5/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Lokanath Lenka on 10/30/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Nilam Patel on 11/1/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Basil Theofanopoulos on 10/29/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Vaibhav Patel on 10/31/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Irina Yakobson on 11/2/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Sachin Bali on 11/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Srikant Pimple on 11/5/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/27/2018) |
| NOTICE to Take Deposition of Govind Dagdu Shinde on 10/29/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/28/2018) |
| NOTICE to Take Deposition of Qibiao Huang on 11/13/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/28/2018) |
| NOTICE to Take Deposition of Jinsong You on 11/14/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/28/2018) |
| NOTICE to Take Deposition of Digesh Patel on 10/25/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/28/2018) |
| NOTICE to Take Deposition of Pavak Mehta on 10/26/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 09/28/2018) |
| NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendants Second Set of Joint Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 10/01/2018) |
| NOTICE OF SERVICE of Privilege Log of Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA, Inc. filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 10/01/2018) |
| NOTICE to Take Deposition of Shoba Chagam on 11/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE to Take Deposition of Yong (Eddy) Chen on 11/5/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE to Take Deposition of Mangesh Shahane on 10/25/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE to Take Deposition of Pravin Maurya on 10/26/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE to Take Deposition of Chintan Dholakia on 11/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE to Take Deposition of Srinivas Guram/G. Srinivas on 11/5/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/02/2018) |
| NOTICE OF SERVICE of Plaintiffs Corrected First Amended Supplemental Objections & Responses to Defendants First Set of Joint Interrogatories filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 10/05/2018) |
| NOTICE to Take Deposition of Arjit Das on 11/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/08/2018) |
| NOTICE to Take Deposition of Bijay Padhi on 11/20/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/08/2018) |
| NOTICE OF SERVICE of (1) Supplemental Initial Disclosures of Unichem Laboratories, Ltd. Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Unichem Laboratories, Ltd.s Supplemental Responses and Objections to Plaintiffs Interrogatory Nos. 11, 12, 14 and 16 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 10/09/2018) |
| MOTION for Pro Hac Vice Appearance of Attorney Wenbo Zhang, Charles T. Cox, Jr., Michael Nelson, and Wenli Gu - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 10/09/2018) |
| NOTICE to Take Deposition of Vimal Kaneria on 10/31/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/10/2018) |
| NOTICE to Take Deposition of G. Kesevan on 11/2/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/10/2018) |
| NOTICE to Take Deposition of Elizabeth Purcell on 11/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/10/2018) |
| NOTICE to Take Deposition of Kumar Singh on 11/14/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/10/2018) |
| NOTICE of Deposition of Stephanie Koch on October 16-17, 2018 by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. (Connolly, Arthur) (Entered: 10/11/2018) |
| NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests for Admission to Defendant Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.; (2) Plaintiffs First Set of Requests for Admission to Defendant Mylan Pharmaceuticals Inc.; (3) Plaintiffs First Set of Requests for Admission to Defendants HEC Pharm USA Inc. and Sunshine Lake Pharma Co., Ltd.; (4) Plaintiffs First Set of Requests for Admission to Defendant Unichem Laboratories, Ltd.; (5) Plaintiffs First Set of Requests for Admission to Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.; (6) Plaintiffs First Set of Requests for Admission to Defendant Indoco Remedies Ltd.; (7) Plaintiffs First Set of Requests for Admission to Defendant Sandoz Inc.; (8) Plaintiffs First Set of Requests for Admission to Defendant Sigmapharm Laboratories, LLC; and (9) Plaintiffs First Set of Requests for Admission to Defendant Zydus Pharmaceuticals (USA) Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 10/12/2018) |
| NOTICE OF SERVICE of Plaintiffs Objections and Responses to Sigmapharm Laboratories, LLCs First Set of Interrogatories to Plaintiffs (Nos. 1-4) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 10/15/2018) |
| NOTICE to Take Deposition of V. Naga Prasad on 11/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Roopak Sawhney on 11/20/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Adity Sen Pal on 11/8/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Sapna Ramesh on 11/9/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Vatsal Shah on 11/20/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Mateja Sikovec on 11/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Melissa Henry on 11/6/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Tijana Ljubin on 11/8/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/16/2018) |
| NOTICE to Take Deposition of Sachin Arora on 11/14/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of ERR Chandrasekhar on 11/16/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of Anuj Srivastava on 10/25/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of Kavita Inamdar on 11/15/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of Vimal Kaneria on 10/31/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of G. Kesevan on 11/2/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/17/2018) |
| NOTICE to Take Deposition of Bradley Davis on 10/24/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/18/2018) |
| NOTICE to Take Deposition of Grant Heinicke on 11/20/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/18/2018) |
| NOTICE to Take Deposition of David Mitchell on 11/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/18/2018) |
| MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 10/18/18. (ntl) (Entered: 10/18/2018) |
| ORDER re 380 Memorandum Opinion re claim construction; 258 MOTION to Strike filed by Unichem Laboratories, Ltd. is DENIED. Signed by Judge Leonard P. Stark on 10/18/18. (ntl) (Entered: 10/18/2018) |
| MEMORANDUM OPINION re 178 motion to dismiss. Signed by Judge Leonard P. Stark on 10/18/18. Associated Cases: 1:17-cv-00374-LPS, 1:17-cv-00379-LPS (ntl) (Entered: 10/18/2018) |
| ORDER re (382 in 1:17-cv-00374-LPS, 69 in 1:17-cv-00379-LPS) Memorandum Opinion -- (178 in 1:17-cv-00374-LPS) MOTION to Dismiss or Transfer filed by Mylan Pharmaceuticals Inc. is GRANTED. Signed by Judge Leonard P. Stark on 10/18/18. Associated Cases: 1:17-cv-00374-LPS, 1:17-cv-00379-LPS (ntl) (ntl). (Entered: 10/18/2018) |
| NOTICE to Take Deposition of Elizabeth Purcell Pastor on 11/6/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/19/2018) |
| NOTICE to Take Deposition of Kumar Singh on 11/14/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/19/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Request for Discovery Teleconference. (Farnan, Michael) (Entered: 10/19/2018) |
| NOTICE to Take Deposition of Elizabeth Purcell Pastor on 11/9/2018 (Second Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/19/2018) |
| NOTICE OF SERVICE of Sigmapharm Laboratories, LLCs (1) [CONFIDENTIAL] First Set of Requests for Admission to Plaintiffs (Nos. 1-15); and (2) [CONFIDENTIAL] Second Set of Defendant Interrogatories to Plaintiffs (Nos. 5-9) filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 10/19/2018) |
| NOTICE OF SERVICE of 1) Sandoz Inc.s First Requests for Admission to Plaintiffs (Nos. 1-57), and 2) Defendant Sandoz Inc.s First Set of Individual Requests for Production to Plaintiffs (No. 1) filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 10/19/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd., HEC Pharm USA Inc., and Unichem Laboratories Ltd.s First Set of Requests for Admissions to Bristol-Myers Squibb Company and Pfizer Inc. filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd..(Pascale, Karen) (Entered: 10/19/2018) |
| NOTICE to Take Deposition of Barry Jacobsen on November 14, 2018 filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 10/19/2018) |
| NOTICE OF SERVICE of (1) Plaintiffs First Set of Interrogatories to Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd.; (2) Plaintiffs First Set of Interrogatories to Defendant Mylan Pharmaceuticals Inc.; (3) Plaintiffs First Set of Interrogatories to Defendants HEC Pharm USA Inc. and Sunshine Lake Pharma Co., Ltd.; (4) Plaintiffs First Set of Interrogatories to Defendant Unichem Laboratories, Ltd.; (5) Plaintiffs First Set of Interrogatories to Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.; (6) Plaintiffs First Set of Interrogatories to Defendant Indoco Remedies Ltd.; (7) Plaintiffs First Set of Interrogatories to Defendant Sandoz Inc.; (8) Plaintiffs First Set of Interrogatories to Defendant Sigmapharm Laboratories, LLC; and (9) Plaintiffs First Set of Interrogatories to Defendant Zydus Pharmaceuticals (USA) Inc. filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 10/19/2018) |
| NOTICE of Withdrawal of Erin M. Forbes by Sandoz Inc. (Gattuso, Dominick) (Entered: 10/24/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Request for Discovery Teleconference between Plaintiffs and Defendant Sigmapharm Laboratories, LLC. (Farnan, Michael) (Entered: 10/25/2018) |
| NOTICE to Take Deposition of Vijay Raghavan on 11/2/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/29/2018) |
| NOTICE to Take Deposition of Vatsal Shah on 11/2/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 10/29/2018) |
| NOTICE OF SERVICE of Plaintiffs Amended Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 11/06/2018) |
| STIPULATION to Amend Scheduling Order by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 11/06/2018) |
| NOTICE to Take Deposition of Govind Dagdu Shinde on 12/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/08/2018) |
| NOTICE to Take Deposition of Mangesh Sahane on 11/16/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/12/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s [CONFIDENTIAL] Second Supplemental Responses and Objections to Plaintiffs Interrogatory No. 6 and Supplemental Responses and Objections to Interrogatory No. 7 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/12/2018) |
| NOTICE to Take Deposition of Arjit Das on 11/19/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/13/2018) |
| NOTICE to Take Deposition of Bijay Padhi. on 11/20/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma LTD.S Response to Plaintiffs First Set of Interrogatories to Individual Defendant Aurobindo and Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma LTD.s Responses to Plaintiffs First Set of Requests for Admission to Defendants Aurobindo re 361 Notice of Service,,,, 392 Notice of Service,,,, filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Defendant Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-22) [Competitively Sensitive Confidential Information of Dr. Reddys - Subject to Protective Order] filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Defendants HEC Pharm USA Inc.s and Sunshine Lake Pharma Co., Ltd.s Response to Plaintiffs First Set of Requests for Admission filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Unichem Laboratories, Ltd.s Responses and Objections to Plaintiffs First Set of Requests for Admission filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Sigmapharm Laboratories, LLCs [CONFIDENTIAL] Responses to Plaintiffs First Set of Requests for Admission to Defendant Sigmapharm Laboratories, LLC filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-30) filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Sandoz Inc.s Objections and Answers to Plaintiffs First Set of Requests for Admission filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 11/13/2018) |
| NOTICE OF SERVICE of Defendants Sunshine Lake Pharma Co., Ltd.s and HEC Pharm USA Inc.s Response to Plaintiffs First Set of Interrogatories to Defendants HEC Pharm USA Inc. and Sunshine Lake Pharma Co., Ltd. filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 11/13/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Discovery Dispute between Plaintiffs and Unichem Laboratories - re 386 Letter. (Farnan, Michael) (Entered: 11/14/2018) |
| ORDER: Consistent with the Memorandum Opinion and Order entered on 10/18/18, IT IS HEREBY ORDERED that C.A. No. 17-379-LPS is DISMISSED WITHOUT PREJUDICE. Signed by Judge Leonard P. Stark on 11/14/18. Associated Cases: 1:17-cv-00374-LPS, 1:17-cv-00379-LPS (ntl) (Entered: 11/15/2018) |
| NOTICE to Take Deposition of Kumar Singh on 12/12/2018 (Second Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/15/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s [CONFIDENTIAL] Supplemental Designated Witnesses in Response to Plaintiffs Rule 30(b)(6) Notice filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/15/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s [CONFIDENTIAL] Second Supplemental Designated Witnesses in Response to Plaintiffs Rule 30(b)(6) Notice filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/15/2018) |
| NOTICE OF SERVICE of Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.s Responses And Objections To Plaintiffs First Set Of Interrogatories To Defendants Dr. Reddys Laboratories, Inc. And Dr. Reddys Laboratories, Ltd. (No. 1) [COMPETITIVELY SENSITIVE CONFIDENTIAL INFORMATION OF DR. REDDYS SUBJECT TO PROTECTIVE ORDER] filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 11/19/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s Responses and Objections to Plaintiffs First Set of Interrogatories (No. 1) filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 11/19/2018) |
| NOTICE OF SERVICE of Sigmapharm Laboratories, LLCs Answers and Objections to Plaintiffs First Set of Interrogatories to Defendant Sigmapharm Laboratories, LLC filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 11/19/2018) |
| NOTICE OF SERVICE of Sandoz Inc.s REsponse to Plaintiffs First Set of Interrogatories to Sandoz (Designated Confidential - Subjectd to Protective Order and this Notice of Service filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 11/19/2018) |
| NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Objections and Responses to Plaintiffs First Set of Interrogatories to Defendant Zydus Pharmaceuticals (USA) Inc. (No. 1) filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 11/19/2018) |
| NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to Sandoz Inc.s First Requests for Admission (Nos. 1-57); (2) Plaintiffs Objections and Responses to Defendant Sandoz Inc.s First Set of Individual Requests for Production; (3) Plaintiffs Objections and Responses to Sigmapharm Laboratories, LLCs Second Set of Interrogatories to Plaintiffs (Nos. 5-9); (4) Plaintiffs Responses and Objections to Sigmapharm Laboratories, LLCs First Set of Requests for Admission to Plaintiffs (Nos. 1-15); and (5) Plaintiffs Objections and Responses to Sunshine Lake Pharma Co., Ltd., HEC Pharm USA Inc., and Unichem Laboratories Ltd.s First Set of Requests for Admission (Nos. 1-15) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 11/19/2018) |
| NOTICE to Take Deposition of Bapuji A.T. on 12/17/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of Nilesh Bhandari on 12/18/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of D. Krishnama Chary on 12/17/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of K.K.C. Dasarathi on 12/20/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of Prince Kumar Devadas on 12/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of V.K. Handa on 12/17/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of V. Sumathi Rao on 12/18/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of Arnab Roy on 12/18/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| NOTICE to Take Deposition of Hemant Kumar Sharma on 12/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 11/20/2018) |
| [SEALED] Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Response to Sigmapharms November 20, 2018 Letter - re 427 Letter. (Farnan, Michael) (Entered: 11/26/2018) |
| Joint Letter to The Honorable Leonard P. Stark from Brian E. Farnan regarding Request for Discovery Teleconference. (Farnan, Brian) (Entered: 11/30/2018) |
| STIPULATION of Dismissal (Indoco Remedies Ltd.) by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 11/30/2018) |
| REDACTED VERSION of 438 Letter by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/03/2018) |
| NOTICE of of Intent to Request Redactions by Sigmapharm Laboratories LLC (Phillips, John) (Entered: 12/03/2018) |
| NOTICE to Take Deposition of Weiheng (Kevin) Kong on 12/11/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/04/2018) |
| NOTICE to Take Deposition of Spiro Spireas on 12/19/2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/06/2018) |
| NOTICE to Take Deposition of Disha Patel on 12/11/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/06/2018) |
| NOTICE to Take Deposition of Lokanath Lenka on 12/12/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/06/2018) |
| NOTICE to Take Deposition of Basil Theofanopoulos on 12/18/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/06/2018) |
| NOTICE to Take Deposition of Srinivas Gurram on December 20, 2018 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 12/07/2018) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding transcript of November 30, 2018 teleconference. (Phillips, John) (Entered: 12/07/2018) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Request to Cancel December 21, 2018 Hearing - re 451 Order Setting Teleconference,,,,. (Farnan, Michael) (Entered: 12/11/2018) |
| SO ORDERED, re 441 Stipulation of Dismissal filed by Pfizer Inc., Bristol-Myers Squibb Company -- Party Indoco Remedies Ltd. terminated. Attorney Thomas A. Haag; Jamaica P. Szeliga; Sean M. Brennecke and Dean L. Fanelli terminated. Signed by Judge Leonard P. Stark on 12/10/18. (ntl) (Entered: 12/11/2018) |
| [SEALED] Transcript of Telephone Conference held on November 30, 2018 before Chief Judge Leonard P. Stark. (bpg) (Entered: 12/12/2018) |
| ORDER re 454 MOTION to Redact Transcript (Unopposed) filed by Sigmapharm Laboratories LLC. Signed by Judge Leonard P. Stark on 12/13/18. (ntl) (Entered: 12/13/2018) |
| NOTICE OF SERVICE of Defendants HEC Pharm USA Inc.s and Sunshine Lake Pharma Co., Ltd.s Second Supplemental Response to Plaintiffs First Set of Common Interrogatories filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Vrana, Robert) (Entered: 12/14/2018) |
| NOTICE OF SERVICE of Unichem Laboratories, Ltd.s [CONFIDENTIAL] Supplemental Responses and Objections to Plaintiffs Common Interrogatory Nos. 1-17 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 12/20/2018) |
| NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] First Supplemental Response to Plaintiffs Common Interrogatory No. 6 filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 12/20/2018) |
| NOTICE OF SERVICE of Defendant Sandoz Inc.s Second Supplemental Objections and Answers to Plaintiffs First Set of Common Interrogatories (Nos. 6,7) (designated Confidential - Subject to Protective Order] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 12/20/2018) |
| NOTICE OF SERVICE of Defendants First Supplemental Response to Plaintiffs Common Interrogatory No. 6 (Competitively Sensitive Confidential Information of Dr. Reddys - Subject to Protective Order) and Defendants First Supplemental Objections and Responses to Plaintiffs Second Set of Common Interrogatories (Nos. 11-12 and 16) (Competitively Sensitive Confidential Information of Dr. Reddys - Subject to Protective Order) filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 12/20/2018) |
| NOTICE to Take Deposition of Shoba Chagam on 1/10/2019 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 12/20/2018) |
| NOTICE OF SERVICE of (1) Plaintiffs Second Amended and Supplemental Objections and Responses to Defendants First Set of Joint Interrogatories (Nos. 1-17); (2) Plaintiffs First Amended and Supplemental Objections and Responses to Defendants Second Set of Joint Interrogatories (Nos. 18-21); (3) Plaintiffs First Amended and Supplemental Objections and Responses to Sunshine Lake Pharma Co. Ltd.s and HEC Pharm USA Inc.s First Set of Interrogatories; (4) Plaintiffs First Amended and Supplemental Objections and Responses to Sigmapharm Laboratories, LLCs First Set of Interrogatories to Plaintiffs (Nos. 1-4); and (5) Plaintiffs First Amended and Supplemental Objections and Responses to Sigmapharm Laboratories, LLCs Second Set of Interrogatories to Plaintiffs (Nos. 5-9) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 12/20/2018) |
| NOTICE to Take Deposition of Digesh Patel on 12/28/2018 (Amended) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 12/21/2018) |
| Redaction of 455 Transcript. Telephone conference held on November 30, 2018 before Chief Judge Stark. Court Reporter, Brian Gaffigan (302) 573-6360. (bpg) (Entered: 12/28/2018) |
| Interim STATUS REPORT by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Main Document 468 replaced on 1/4/2019) (etg). (Entered: 01/04/2019) |
| STIPULATION TO EXTEND TIME to EXTEND the deadline for Plaintiffs Final Infringement Contentions for Sunshine Lake Defendants to 2/1/2019 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 01/23/2019) |
| NOTICE OF SERVICE of Bristol-Myers Squibb Company and Pfizer Inc.s Final Infringement Contentions filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 01/25/2019) |
| NOTICE OF SERVICE of Defendants Amended Invalidity Contentions Relating to U.S. Patent No. 9,326,945 [Confidential - Subject to Protective Order] filed by Sandoz Inc..(Gattuso, Dominick) (Entered: 01/25/2019) |
| NOTICE OF SERVICE of Defendants Supplemental Invalidity Contentions Relating to U.S. Patent No. 6,697,208 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 01/25/2019) |
| NOTICE OF SERVICE of Plaintiffs Final Infringement Contentions (Sunshine Lake) filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 02/01/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding request for discovery dispute teleconference. (Phillips, John) (Entered: 02/05/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Kendall K. Gurule - filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Pascale, Karen) (Entered: 02/08/2019) |
| NOTICE OF SERVICE of Expert Report of Clayton H. Heathcock, Ph.D. filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 02/18/2019) |
| NOTICE OF SERVICE of Opening Expert Report of Salvatore D. Lepore, Ph.D. on Invalidity of U.S. Patent No. 6,967,208 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 02/18/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Opening Expert Report of Walter G. Chambliss, Ph.D. filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 02/18/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Expert Report of Dr. Graham Buckton, BPharm, AKC, C.Dir, PhD, DSc, CChem, FRSC, FAPS, FAAPS, FRPharmS filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 02/18/2019) |
| NOTICE OF SERVICE of (1) Opening Expert Report of Peter R. Kowey, M.D. Concerning Aurobindos Infringement of U.S. Patent No. 6,967,208; (2) Opening Expert Report of David W.C. Macmillan, Ph.D. Concerning Aurobindos Infringement of U.S. Patent No. 6,967,208; (3) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Aurobindo of U.S. Patent No. 9,326,945; (4) Opening Expert Report of Peter R. Kowey, M.D. Concerning Unichems Infringement of U.S. Patent No. 6,967,208; (5) Opening Expert Report of David W.C. Macmillan, Ph.D. Concerning Unichems Infringement of U.S. Patent No. 6,967,208; (6) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Defendant Unichem Laboratories, Ltd. of U.S. Patent No. 9,326,945; (7) Opening Expert Report of Cory J. Berkland, Ph.D. Regarding Infringement by Defendant Unichem Laboratories, Ltd. of U.S. Patent No. 9,326,945; (8) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Dr. Reddys Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (9) Opening Expert Report of Dr. Eric Munson Regarding Infringement by Defendant Dr. Reddys Laboratories Limited of U.S. Patent No. 9,326,945; (10) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Sandoz Inc. of U.S. Patent No. 9,326,945; (11) Opening Expert Report of Peter R. Kowey, M.D. Concerning Sigmapharms Infringement of U.S. Patent No. 6,967,208; (12) Opening Expert Report of David W.C. Macmillan, Ph.D. Concerning Sigmapharms Infringement of U.S. Patent No. 6,967,208; (13) Opening Expert Report of Dr. Eric Munson Regarding Infringement by Defendant Sigmapharm Laboratories, LLC of U.S. Patent No. 9,326,945; (14) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Sigmapharm Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (15) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA Inc. of U.S. Patent No. 9,326,945; (16) Opening Expert Report of Peter R. Kowey, M.D. Concerning Zyduss Infringement of U.S. Patent No. 6,967,208; (17) Opening Expert Report of David W.C. Macmillan, Ph.D. Concerning Zyduss Infringement of U.S. Patent No. 6,967,208; (18) Opening Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Zydus Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (19) Opening Expert Report of Dr. Eric Munson Regarding Infringement By Defendant Zydus Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 02/19/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding February 5, 2019 letter - re 474 Letter. (Phillips, John) (Entered: 02/19/2019) |
| NOTICE of Change of Address by Arthur G. Connolly, III (Connolly, Arthur) (Entered: 02/28/2019) |
| STIPULATION Regarding Infringement between Plaintiffs and Defendant Unichem Laboratories, Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 03/29/2019) |
| STIPULATION TO EXTEND TIME for Plaintiffs and Defendant Sandoz Inc. to serve (i) Responsive Expert Reports concerning infringement of U.S. Patent No. 9,326,945 and (ii) Reply Expert Reports to (i) 4/24/2019 and (ii) 5/22/2019 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 04/15/2019) |
| STIPULATION TO EXTEND TIME for Defendants to serve their responsive expert report and Plaintiffs to serve their reply(ies) to Defendants responsive expert report to April 19, 2019 and May 17, 2019, respectively - filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd.. (Moore, David) (Entered: 04/17/2019) |
| NOTICE OF SERVICE of (i) Rebuttal Expert Report of Eric N. Jacobsen, Ph.D.; (ii) Expert Report of Michael E. Tate; (iii) Rebuttal Expert Report of Peter R. Kowey, M.D. Concerning Validity of U.S. Patent No. 6,967,208; (iv) Rebuttal Expert Report of Allan S. Myerson, Ph.D. Regarding the Validity of U.S. Patent No. 9,326,945 and U.S. Patent No. 6,697,208; and (v) Rebuttal Expert Report of David W.C. Macmillan, Ph.D., concerning Validity of U.S. Patent No. 6,967,208 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 04/17/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Rebuttal Noninfringement Expert Report of Defendant Unichems Expert Witness Wayne J. Genck, Ph.D. filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 04/17/2019) |
| NOTICE OF SERVICE of Rebuttal Expert Report of Harry G. Brittain, Ph.D., FAAPS, FRSC filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 04/17/2019) |
| NOTICE OF SERVICE of Defendant Zydus Pharmaceuticals (USA) Inc.s [CONFIDENTIAL] Rebuttal Expert Report of Mark J. Sacchetti, Ph.D., Regarding Noninfringement filed by Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 04/18/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Rebuttal Expert Report of Clayton R. Heathcock, Ph.D. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 04/18/2019) |
| NOTICE OF SERVICE of (1) Sigmapharm Laboratories, LLCs [COMPETITIVELY SENSITIVE/TRADE SECRET/CONFIDENTIAL] Responsive Report of Robert Schurko, Ph.D.; (2) Sigmapharm Laboratories, LLCs [COMPETITIVELY SENSITIVE/TRADE SECRET/CONFIDENTIAL] Rebuttal Expert Report of Michael Zaworotko, Ph.D.; and (3) Sigmapharm Laboratories, LLCs [COMPETITIVELY SENSITIVE/CONFIDENTIAL] Rebuttal Expert Report of David Apperley, Ph.D. filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 04/18/2019) |
| NOTICE OF SERVICE of Rebuttal Expert Report Of Bart Kahr, Ph.D., Regarding Noninfringement Of U.S. Patent No. 9,326,945 [Competitively Sensitive Confidential Information Of Dr. Reddys Subject To Protective Order] filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(Moore, David) (Entered: 04/22/2019) |
| STIPULATION between Plaintiffs and Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. regarding Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 04/22/2019) |
| STIPULATION TO EXTEND TIME for Plaintiffs and Defendant Sandoz Inc. to serve: (i) Responsive Expert Reports and (i) Reply Expert Reports concerning infringement of U.S. Patent No. 9,326,945 to (i) 4/29/2019 and (ii) 5/28/2019 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 04/24/2019) |
| STIPULATION of Dismissal between Plaintiff and Defendant Sandoz Inc. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/02/2019) |
| STIPULATION TO EXTEND TIME to serve Reply Expert Reports to 5/22/2019 - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 05/10/2019) |
| NOTICE to Take Deposition of Harry Brittain on 6/4/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of DeForest McDuff on 6/5/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Walter Chambliss on 6/14/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Graham Buckton on 6/21/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Wayne Genck on 6/28/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Mark Sacchetti on 7/9/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of David Apperley on 7/10/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Bart Kahr on 7/16/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Michael Zaworotko on 7/17/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Robert Schurko on 7/19/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Clayton Heathcock on 7/24/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE to Take Deposition of Salvatore Lepore on 7/26/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/22/2019) |
| NOTICE OF SERVICE of Reply Expert Report of Clayton H. Heathcock, Ph.D. Regarding Improper Dependency and the Undefined "Z" Term in U.S. Patent No. 6,967,208 filed by Sigmapharm Laboratories LLC.(Bilson, David) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Reply Expert Report of Karl A. Scheidt Ph.D. Regarding Lack of Enablement and Written Description of U.S. Patent No. 6,967,208 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Reply Expert Report of Dr. Graham Buckton, BPharm, AKC, C.Dir, PhD, DSc, CChem, FRSC, FAPS, FAAPS, FRPharmS filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of [CONFIDENTIAL] Reply Expert Report of Walter G. Chambliss, Ph.D. filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of Reply Expert Report of Salvatore D. Lepore, Ph.D. on Invalidity of U.S. Patent No. 6,967,208 and the [CONFIDENTIAL] Expert Report of DeForest McDuff, Ph.D. filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of (1) Reply Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA Inc. of U.S. Patent No. 9,326,945; (2) Reply Expert Report of Jerry L. Atwood, Ph.D. regarding Infringement by Zydus Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (3) Reply Expert Report of Dr. Eric Munson Regarding Infringement by Defendant Zydus Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (4) Reply Expert Report of David W.C. MacMillan, Ph.D., concerning Infringement of U.S. Patent No. 6,967,208 by Zydus Pharmaceuticals (USA) Inc.; (5) Reply Expert Report of Cory J. Berkland, Ph.D. Regarding Infringement by Unichem Laboratories, Ltd. of U.S. Patent No. 9,326,945; (6) Reply Expert Report of Allan S. Myerson, Ph.D. Regarding Validity Issues Raised by Dr. Gencks Rebuttal Expert Report on Noninfringement by Unichem Laboratories, Ltd.; (7) Reply Expert Report of Jerry L. Atwood, Ph.D. Regarding Infringement by Dr. Reddys Pharmaceuticals (USA) Inc. of U.S. Patent No. 9,326,945; (8) Reply Expert Report of Dr. Eric Munson Regarding Infringement by Dr. Reddys of U.S. Patent No. 9,326,945; (9) Reply Expert Report of David W.C. MacMillan, Ph.D., concerning Infringement of U.S. Patent No. 6,967,208 by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd., and Sigmapharm Laboratories, LLC (10) Reply Expert Report of Jerry L. Atwood, Ph.D. regarding Infringement by Sigmapharm Laboratories, LLC of U.S. Patent No. 9,326,945; and (11) Reply Expert Report of Dr. Eric Munson regarding Infringement by Defendant Sigmapharm Laboratories, LLC of U.S. Patent No. 9,326,945 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Brian) (Entered: 05/23/2019) |
| NOTICE OF SERVICE of Reply Expert Report of Dr. Randall Zusman, M.D. on Secondary Considerations and Pharmaceutical Salts in Reply to Rebuttal Expert Report Of Dr. Peter R. Kowey, M.D. Concerning Validity of Asserted Claims 52- 57, 59 - 61, 106 - 108, And 110 - 112 of U.S. Patent No. 6,967,208 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Connolly, Arthur) (Entered: 05/23/2019) |
| NOTICE to Take Deposition of Randall Zusman on 7/19/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Jerry L. Atwood, Ph.D. on June 4, 2019 filed by Sigmapharm Laboratories LLC.(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Jerry L. Atwood, Ph.D. on June 5, 2019 filed by Unichem Laboratories, Ltd..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Cory J. Berkland, Ph.D. on July 10, 2019 filed by Unichem Laboratories, Ltd..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Jerry Atwood on August 1, 2019 filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of David W.C. MacMillan, Ph.D. on July 11-12, 2019 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Peter R. Kowey, MD on June 12, 2019 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Eric Jacobsen, Ph.D. on July 3, 2019 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Michael Tate on June 19, 2019 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Allan S. Myerson, Ph.D. on June 13, 2019 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Eric Munson, Ph.D. on July 29-30, 2019 filed by Sigmapharm Laboratories LLC, Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Eric Munson on July 29, 2019 filed by Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd..(OByrne, Stephanie) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of David MacMillan on July 12, 2019 filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Jerry Atwood on August 2, 2019 filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Eric Munson on July 30, 2019 filed by Zydus Pharmaceuticals (USA) Inc..(Phillips, John) (Entered: 05/29/2019) |
| NOTICE to Take Deposition of Jerry L. Atwood, Ph.D. on June 6, 2019 filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd..(Pascale, Karen) (Entered: 05/30/2019) |
| NOTICE to Take Deposition of Karl Scheidt on 7/3/2019 filed by Bristol-Myers Squibb Company, Pfizer Inc..(Farnan, Michael) (Entered: 06/03/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Alexis Cohen - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 06/03/2019) |
| STIPULATION TO EXTEND TIME to EXTEND the deadlines to: (i) file Daubert motions; (ii) file any opposition to any Daubert motion; and (iii) file any reply in support of a Daubert motion to (i) 8/7/2019; (ii) 8/22/2019; and (iii) 8/30/2019 respectively - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/05/2019) |
| NOTICE to Take Deposition of Allan S. Myerson, Ph.D. on July 17, 2019 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 06/12/2019) |
| STIPULATION TO EXTEND TIME to file (i) answering brief and (ii) reply brief for Sigmapharms motion to strike to (i) July 1, 2019 and (ii) July 9, 2019 - filed by Bristol-Myers Squibb Company. (Farnan, Brian) (Entered: 06/24/2019) |
| STIPULATION of Dismissal as to Defendants Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc. by Dr. Reddys Laboratories, Inc., Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories Inc., Dr. Reddys Laboratories Ltd.. (OByrne, Stephanie) (Entered: 06/25/2019) |
| STIPULATION TO EXTEND TIME to Respond to Motion to Strike and Reply in Support of Motion to Strike to July 1, 2019 and July 9, 2019, respectively - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/26/2019) |
| REDACTED VERSION of 537 Letter, by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 06/27/2019) |
| STATUS REPORT Regarding Trial Dates by Bristol-Myers Squibb Company. (Farnan, Brian) (Entered: 06/28/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding request for discovery teleconference. (Phillips, John) (Entered: 07/01/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney William F. Lee - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 07/02/2019) |
| STIPULATION TO EXTEND TIME for Plaintiffs to file a redacted public version of their July 1, 2019 [SEALED] Answering Letter Brief (D.I. 545) in opposition to Sigmapharms Motion to Strike to July 11, 2019 - filed by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 07/08/2019) |
| [SEALED] Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Reply Letter in Support of Defendant Sigmapharm Laboratories, LLCs Motion to Strike. (Phillips, John) (Entered: 07/09/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding the parties respectfully request a teleconference with the Court to address defendant Sigmapharm Laboratories, LLCs Motion to Strike (D.I. 536). (Phillips, John) (Entered: 07/09/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney William G. McElwain - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 07/10/2019) |
| REDACTED VERSION of 549 Letter by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 07/16/2019) |
| NOTICE to Take Deposition of Allan S. Myerson, Ph.D. on July 22, 2019 filed by Unichem Laboratories, Ltd..(Bilson, David) (Entered: 07/17/2019) |
| NOTICE requesting Clerk to remove Tracey C. Allen as co-counsel.. (Farnan, Brian) (Entered: 07/30/2019) |
| ORDER Setting Mediation Conference: A Telephone Conference is set for 8/12/2019 at 10:45 AM before Judge Christopher J. Burke to discuss alternative dispute resolutions. Signed by Judge Christopher J. Burke on 8/1/2019. (dlb) (Entered: 08/01/2019) |
| STIPULATION regarding Pretrial Deadlines by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/02/2019) |
| [SEALED] MOTION to Preclude a Portion of the Testimony of Wayne J. Genck, Ph.D. - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/07/2019) |
| [SEALED] MOTION to Preclude Portions of the Non-Infringement Testimony of Robert Schurko and David Apperley - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/07/2019) |
| [SEALED] MOTION to Preclude Portions of the Non-Infringement Testimony of Michael Zaworotko, Ph.D. - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/07/2019) |
| [SEALED] OPENING BRIEF in Support re 567 MOTION to Preclude Motion to Exclude Expert Testimony of Cory J. Berkland, Ph.D. filed by Unichem Laboratories, Ltd..Answering Brief/Response due date per Local Rules is 8/21/2019. (Phillips, John) (Entered: 08/07/2019) |
| [SEALED] EXHIBIT re 568 Opening Brief in Support, Exhibits to Opening Brief in Support of Motion to Exclude Expert Testimony of Cory J. Berkland, Ph.D. by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 08/07/2019) |
| [SEALED] OPENING BRIEF in Support re 570 MOTION to Preclude Sigmapharms Daubert Motion to Exclude Certain Experts filed by Sigmapharm Laboratories LLC.Answering Brief/Response due date per Local Rules is 8/21/2019. (Phillips, John) (Entered: 08/07/2019) |
| [SEALED] EXHIBIT re 571 Opening Brief in Support, Exhibits to Opening Brief in Support of Sigmapharms Daubert Motion to Exclude Certain Experts by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/07/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding request for leave to move for summary judgment. (Phillips, John) (Entered: 08/09/2019) |
| REDACTED VERSION of 568 Opening Brief in Support, by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 08/14/2019) |
| REDACTED VERSION of 569 Exhibit to a Document by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 08/14/2019) |
| REDACTED VERSION of 571 Opening Brief in Support, by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/14/2019) |
| REDACTED VERSION of 563 MOTION to Preclude Portions of the Non-Infringement Testimony of Robert Schurko and David Apperley by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 565 MOTION to Preclude Portions of the Non-Infringement Testimony of Michael Zaworotko, Ph.D. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/14/2019) |
| REDACTED VERSION of 560 MOTION to Preclude a Portion of the Testimony of Wayne J. Genck, Ph.D. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/14/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Reply to Plaintiffs August 14, 2019 Letter - re 587 Letter,. (Phillips, John) (Entered: 08/15/2019) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding request for discovery dispute conference. (Phillips, John) (Entered: 08/22/2019) |
| [SEALED] RESPONSE to Motion re 559 MOTION to Preclude Portions of the Non-Infringement Testimony of Harry G. Brittain, Ph.D. filed by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Pascale, Karen) (Entered: 08/22/2019) |
| [SEALED] ANSWERING BRIEF in Opposition re 567 MOTION to Preclude Motion to Exclude Expert Testimony of Cory J. Berkland, Ph.D. filed by Bristol-Myers Squibb Company, Pfizer Inc..Reply Brief due date per Local Rules is 8/29/2019. (Farnan, Brian) (Entered: 08/22/2019) |
| [SEALED] ANSWERING BRIEF in Opposition re 563 MOTION to Preclude Portions of the Non-Infringement Testimony of Robert Schurko and David Apperley filed by Sigmapharm Laboratories LLC.Reply Brief due date per Local Rules is 8/29/2019. (Phillips, John) (Entered: 08/22/2019) |
| [SEALED] ANSWERING BRIEF in Opposition re 570 MOTION to Preclude Sigmapharms Daubert Motion to Exclude Certain Experts filed by Bristol-Myers Squibb Company, Pfizer Inc..Reply Brief due date per Local Rules is 8/29/2019. (Farnan, Brian) (Entered: 08/22/2019) |
| [SEALED] ANSWERING BRIEF in Opposition re 565 MOTION to Preclude Portions of the Non-Infringement Testimony of Michael Zaworotko, Ph.D. filed by Sigmapharm Laboratories LLC.Reply Brief due date per Local Rules is 8/29/2019. (Phillips, John) (Entered: 08/22/2019) |
| [SEALED] Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Discovery Dispute - re 589 Order,,,. (Phillips, John) (Entered: 08/22/2019) |
| STIPULATION regarding Pretrial Exchanges by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/23/2019) |
| [SEALED] Letter to the Honorable Leonard P. Stark from Stamatios Stamoulis regarding Responsive Discovery Dispute Letter - re 608 Letter,. (Stamoulis, Stamatios) (Entered: 08/23/2019) |
| STIPULATION of Dismissal between Plaintiffs and Defendants Aurobindo Pharma USA Inc. and Aurobindo Pharma Ltd. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/26/2019) |
| REDACTED VERSION of 594 Response to Motion by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Pascale, Karen) (Entered: 08/26/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Shirley X. Li Cantin - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/27/2019) |
| REDACTED VERSION of 597 Answering Brief in Opposition, by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/29/2019) |
| REDACTED VERSION of 601 Answering Brief in Opposition, by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/29/2019) |
| REDACTED VERSION of 605 Letter by HEC Pharm USA Inc., Sigmapharm Laboratories LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) (Entered: 08/29/2019) |
| REDACTED VERSION of 606 Declaration, by HEC Pharm USA Inc., Sigmapharm Laboratories LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Phillips, John) (Entered: 08/29/2019) |
| REDACTED VERSION of 598 Answering Brief in Opposition, by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/29/2019) |
| REDACTED VERSION of 600 Declaration by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/29/2019) |
| REDACTED VERSION of 603 Answering Brief in Opposition, by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/29/2019) |
| REDACTED VERSION of 604 Declaration by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/29/2019) |
| [SEALED] REPLY BRIEF re 559 MOTION to Preclude Portions of the Non-Infringement Testimony of Harry G. Brittain, Ph.D. filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 560 MOTION to Preclude a Portion of the Testimony of Wayne J. Genck, Ph.D. filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 562 MOTION to Preclude Portions of the Non-Infringement Testimony of Mark Sacchetti, Ph.D. filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 563 MOTION to Preclude Portions of the Non-Infringement Testimony of Robert Schurko and David Apperley filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 565 MOTION to Preclude Portions of the Non-Infringement Testimony of Michael Zaworotko, Ph.D. filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 08/30/2019) |
| REDACTED VERSION of 609 Letter by Mylan Pharmaceuticals Inc.. (Stamoulis, Stamatios) (Entered: 08/30/2019) |
| [SEALED] REPLY BRIEF re 570 MOTION to Preclude Sigmapharms Daubert Motion to Exclude Certain Experts filed by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 08/30/2019) |
| REDACTED VERSION of 628 Reply Brief by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 630 Reply Brief by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 632 Reply Brief by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 634 Reply Brief by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/06/2019) |
| REDACTED VERSION of 635 Reply Brief by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/06/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Jonathan B. Turpin - filed by Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 09/06/2019) |
| REDACTED VERSION of 641 Reply Brief in Support of its Daubert Motion to Exclude Certain Experts by Sigmapharm Laboratories LLC. (Bilson, David) (Entered: 09/06/2019) |
| STIPULATION and Proposed Order to Present Testimony of Dr. Graham Buckton Out of Time by HEC Pharm USA Inc., Sigmapharm Laboratories LLC, Sunshine Lake Pharma Co. Ltd., Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc.. (Bilson, David) (Entered: 09/06/2019) |
| MOTION [Motion for Teleconference to Resolve Discovery Dispute] - filed by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 09/06/2019) |
| MOTION [Motion for Teleconference to Resolve Discovery Disputes] - filed by Sigmapharm Laboratories LLC. (Bilson, David) (Entered: 09/09/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Stephen R. Howe and Femi Masha - filed by Sigmapharm Laboratories LLC. (Bilson, David) (Entered: 09/09/2019) |
| Letter to The Honorable Jennifer L. Hall from John C. Phillips, Jr. regarding Discovery Dispute Teleconference - re 657 MOTION [Motion for Teleconference to Resolve Discovery Disputes] . (Phillips, John) (Entered: 09/09/2019) |
| SO ORDERED, re 654 Stipulation and Order to Present Testimony of Dr. Graham Buckton Out of Time on 10/23/2019 at 5:00 PM. Signed by Judge Leonard P. Stark on 9/10/19. (ntl) (Entered: 09/10/2019) |
| STIPULATION to Amend Stipulation Regarding Infringement between Plaintiffs and Defendant Unichem Laboratories, Ltd. re 483 Stipulation by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 09/20/2019) |
| STIPULATION to Narrow the Number of Claims in Dispute by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 09/20/2019) |
| NOTICE requesting Clerk to remove David A. Gerasimow as co-counsel. Reason for request: No Longer Affiliated with the case. (Bilson, David) (Entered: 09/23/2019) |
| NOTICE OF SERVICE of Defendants Notice of Prior Art Under 35 U.S.C. § 282 filed by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd., Zydus Pharmaceuticals (USA) Inc..(Bilson, David) (Entered: 10/01/2019) |
| Official Transcript of Telephone Conference held on September 25, 2019 before Judge Jennifer L. Hall. Court Reporter Brian Gaffigan. To purchase transcript, e-mail: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/7/2019. Redacted Transcript Deadline set for 11/18/2019. Release of Transcript Restriction set for 1/15/2020. (bpg) (Entered: 10/17/2019) |
| MEMORANDUM ORDER re rulings on motions in limine, Daubert motions, and other pretrial matters. Signed by Judge Leonard P. Stark on 10/21/19. (ntl) (ntl). (Entered: 10/21/2019) |
| STIPULATION of Dismissal between Plaintiffs and Defendant Zydus Pharmaceuticals (USA) Inc. by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 10/25/2019) |
| Joint Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Narrowing of Case. (Farnan, Michael) (Entered: 10/30/2019) |
| STIPULATION regarding Density Separation by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 10/31/2019) |
| MOTION for Pro Hac Vice Appearance of Attorney Madeleine Laupheimer - filed by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 10/31/2019) |
| DECLARATION of Jason Mark Scott by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 11/04/2019) |
| NOTICE of Notice of Change of Address for Pro Hac Vice Counsel William L. Mentlik, Paul H. Kochanski, Tedd W. Van Buskirk and Kendall K. Gurule by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd. (Pascale, Karen) (Entered: 11/04/2019) |
| STATUS REPORT Regarding Post-Trial Briefing by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 11/15/2019) |
| POST TRIAL BRIEF on Sigmapharm Laboratories, LLCs Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| POST TRIAL BRIEF on Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA Inc.s Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| POST TRIAL BRIEF on Unichem Laboratories, Ltd.s Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 12/20/2019) |
| POST TRIAL BRIEF Defendants Opening Post-Trial Brief On Invalidity by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 12/20/2019) |
| Proposed Findings of Fact by Sigmapharm Laboratories LLC, Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 12/20/2019) |
| Official Transcript of Bench Trial - Volume A held on October 23, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume B held on October 31, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume C held on November 1, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume D held on November 4, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume E held on November 5, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume F held on November 7, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume G held on November 8, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume H held on November 12, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Official Transcript of Bench Trial - Volume I held on November 13, 2019 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Email: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 1/23/2020. Redacted Transcript Deadline set for 2/3/2020. Release of Transcript Restriction set for 4/1/2020.(bpg) (Entered: 01/02/2020) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/07/2020) |
| POST TRIAL BRIEF Plaintiffs Responsive Post-Trial Brief on Validity of the Asserted Patents by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/07/2020) |
| POST TRIAL BRIEF [Defendant Unichem Laboratories Ltds Responsive Post-Trial Brief on Non-Infringement] by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 02/07/2020) |
| Proposed Findings of Fact by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 02/07/2020) |
| POST TRIAL BRIEF [Defendant Sigmapharm Laboratories, LLCs Responsive Post-Trial Brief on Non-Infringement] by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 02/07/2020) |
| Proposed Findings of Fact by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 02/07/2020) |
| POST TRIAL BRIEF on Noninfringement by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Pascale, Karen) (Main Document 707 replaced on 2/10/2020) (ntl). Modified on 2/10/2020 (ntl). (Entered: 02/07/2020) |
| Proposed Findings of Fact by HEC Pharm USA Inc., Sunshine Lake Pharma Co. Ltd.. (Pascale, Karen) (Main Document 708 replaced on 2/18/2020) (ntl). (Entered: 02/07/2020) |
| POST TRIAL BRIEF [CORRECTED VERSION OF D.I. 703] by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 02/19/2020) |
| Proposed Findings of Fact by Unichem Laboratories, Ltd.. (Phillips, John) (Entered: 02/19/2020) |
| Letter to The Honorable Leonard P. Stark from John C. Phillips, Jr. regarding Defendants admitted trial exhibits. (Phillips, John) (Entered: 02/21/2020) |
| POST TRIAL BRIEF Plaintiffs Reply Post-Trial Brief On Sigmapharm Laboratories, LLCs Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 02/21/2020) |
| POST TRIAL BRIEF Plaintiffs Reply Post-Trial Brief On Sunshine Lake Pharma Co., Ltd. and HEC Pharm USA Inc.s Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 02/21/2020) |
| POST TRIAL BRIEF Plaintiffs Reply Post-Trial Brief On Unichem Laboratories, Ltd.s Infringement by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Brian) (Entered: 02/21/2020) |
| POST TRIAL BRIEF [Defendants Reply Post-Trial Brief on Invalidity (re D.I. 690)] by Sigmapharm Laboratories LLC. (Phillips, John) (Entered: 02/21/2020) |
| POST TRIAL BRIEF [Defendants Corrected Opening Post-Trial Brief on Invalidity (re D.I. 690)] by Sigmapharm Laboratories LLC. (Bilson, David) Modified on 2/24/2020 (etg). (Entered: 02/24/2020) |
| Corrected Proposed Findings of Fact by Sigmapharm Laboratories LLC. (re D.I. 691)(Bilson, David) Modified on 2/24/2020 (etg). (Entered: 02/24/2020) |
| POST TRIAL BRIEF Plaintiffs Corrected Opening Post Trial Brief on Sigmapharm Laboratories, LLCs Infringement (re D.I. 684) by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/26/2020) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/26/2020) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/26/2020) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/26/2020) |
| Proposed Findings of Fact by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 02/26/2020) |
| Letter to The Honorable Leonard P. Stark from David A. Bilson regarding electronic versions of Defendants post-trial briefing. (Bilson, David) (Entered: 02/28/2020) |
| Letter to The Honorable Leonard P. Stark from Michael J. Farnan regarding Hyperlinked Post Trial Documents. (Farnan, Michael) (Entered: 02/28/2020) |
| [SEALED] Letter to the Honorable Leonard P. Stark from David A. Bilson regarding response to Plaintiffs June 17, 2020 letter regarding the statutory stay - re 725 Letter. (Bilson, David) (Entered: 06/19/2020) |
| [SEALED] STATUS REPORT by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/22/2020) |
| [SEALED] Transcript of Status Telephone Conference held on June 19, 2020 before Chief Judge Leonard P. Stark. (bpg) (Entered: 06/23/2020) |
| REDACTED VERSION of 729 Status Report by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 06/24/2020) |
| REDACTED VERSION of 728 Letter by Unichem Laboratories, Ltd.. (Bilson, David) (Entered: 06/29/2020) |
| OPINION re bench trial decision. Signed by Judge Leonard P. Stark on 8/5/20. (ntl) (Entered: 08/05/2020) |
| ORDER re 735 Opinion regarding bench trial decision. Signed by Judge Leonard P. Stark on 8/5/20. (ntl) (Entered: 08/05/2020) |
| PROPOSED ORDER Proposed Order and Final Judgment by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/10/2020) |
| Joint STATUS REPORT by Bristol-Myers Squibb Company, Pfizer Inc.. (Farnan, Michael) (Entered: 08/10/2020) |
| ORDER AND FINAL JUDGMENT in favor of Plaintiffs and against Defendants (See Judgment for further details), ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 8/12/20. (ntl) (Entered: 08/13/2020) |
Timeline
filed_date
closed_date
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2018
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2019
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Patents In Case